FICO’s intrinsic value screens well above the current share price: our deterministic DCF yields $2,283.27 per share versus a live price of $1,063.33, implying roughly 115% upside. The market appears to be mispricing durability, not profitability: investors are paying for a levered capital structure and a supposedly fragile monetization model, while the audited data still show 19.3% revenue growth, 46.5% operating margins, and $769.885M of free cash flow. Our variant view is that the franchise’s cash generation and operating leverage are being underappreciated relative to the risks, so the key debate is whether score monetization holds up long enough to de-risk the balance sheet. This is the executive summary; each section below links to the full analysis tab.
| # | Thesis Point | Evidence |
|---|---|---|
| 1 | FICO is still compounding like a premium franchise, not a mature utility. | FY2025 revenue reached $1.99B, up 19.3% YoY, while diluted EPS rose 29.8% YoY to $26.54. That combination of high-teens top-line growth and near-30% earnings growth indicates pricing power and operating leverage, not ex-growth normalization. |
| 2 | Cash conversion is the core support for the equity story. | Operating cash flow was $778.807M and free cash flow was $769.885M, with a 38.7% FCF margin and just $8.9M of capex. The business is effectively asset-light, so incremental revenue can fall through at a high rate if demand remains intact. |
| 3 | The market is discounting balance-sheet stress far more than operating stress. | At 2025-12-31, long-term debt was $3.20B, total liabilities were $3.66B, cash was only $162.0M, and shareholders’ equity was -$1.81B. The current ratio of 0.93 makes liquidity the key risk, but the operating engine still generates enough cash to service and gradually de-risk the capital structure. |
| 4 | The valuation gap is large, but it depends on durability rather than multiple expansion alone. | The deterministic DCF fair value is $2,283.27 per share versus a live price of $1,063.33, while the reverse DCF implies -3.6% growth at a 3.2% WACC. That tells us the market is pricing a sharp slowdown that is not yet visible in the audited FY2025 operating data. |
| 5 | Quality is real, but the balance sheet keeps this from being a low-risk compounder. | ROIC is 63.1% and ROA is 35.2%, both elite, yet institutional quality rankings are only middling on defense with Safety Rank 3 and Price Stability 40. This is a premium-quality business with a leveraged capital structure, not a plain-vanilla defensive data asset. |
| Date | Event | Impact | If Positive / If Negative |
|---|---|---|---|
| Next earnings release | Upcoming quarterly earnings and guidance update… | HIGH | If positive: confirms revenue and EPS compounding remains near FY2025 pace, supporting rerating toward the DCF range. If negative: any slowdown in score monetization or margin compression could pressure the multiple further. |
| FY2026 annual report / 10-K… | Full-year audited FY2026 results and balance-sheet update… | HIGH | If positive: continued FCF generation and debt reduction would reduce leverage concerns. If negative: higher debt or weaker cash conversion would reinforce the market’s discount on durability. |
| Debt maturity / refinancing milestone… | Potential refinancing or debt management update… | HIGH | If positive: lower refinancing risk and better capital-structure optics. If negative: higher borrowing costs or tighter terms would matter because long-term debt already stands at $3.20B. |
| Product / pricing commentary… | Management commentary on score pricing, volume, and customer adoption… | MEDIUM | If positive: validates monetization durability and the operating leverage case. If negative: weak pricing or lower pull-through would challenge the core variant view. |
| Industry / peer read-through… | Equifax, Verisk, and Broadridge reporting cycle… | MEDIUM | If positive: peer commentary could reinforce resilient demand for information-services workflows. If negative: a softer demand backdrop would make FICO’s premium multiple harder to defend. |
| Period | Revenue | Net Income | EPS |
|---|---|---|---|
| FY2023 | $2.0B | $651.9M | $26.54 |
| FY2024 | $2.0B | $651.9M | $26.54 |
| FY2025 | $2.0B | $652M | $26.54 |
| Method | Fair Value | vs Current |
|---|---|---|
| DCF (5-year) | $2,283 | +118.8% |
| Bull Scenario | $5,373 | +414.9% |
| Bear Scenario | $948 | -9.2% |
| Monte Carlo Median (10,000 sims) | $967 | -7.3% |
| Year | Revenue | Net Income | EPS | Margin |
|---|---|---|---|---|
| 2025 | $1.99B | $651.9M | $26.54 | 32.7% net margin |
Details pending.
Details pending.
As of the latest available data, FICO’s core value driver appears to be holding at a very strong level. The independent institutional survey indicates the FICO Score is used by 90% of top lenders, which is the clearest available measure of current franchise penetration. Against that backdrop, the business generated $924.9M of operating income in FY2025 on $1.87B of total assets, with 46.5% operating margin and 38.7% free cash flow margin, showing that market position is still monetizing efficiently.
The latest balance-sheet data underscores why the market focuses on this driver: FICO ended 2025-12-31 with $3.20B long-term debt, -$1.81B shareholders’ equity, and 0.93 current ratio. That capital structure makes the equity residual highly sensitive to any loss of score franchise durability. In other words, the company is not being valued as a balance-sheet story; it is being valued as a recurring, high-margin scoring franchise that can keep generating cash despite leverage.
Recent per-share metrics reinforce the same point. Revenue per share increased from $70.41 in 2024 to $83.78 in 2025, while EPS rose from $20.45 to $29.91 in the institutional survey. This is exactly the kind of per-share compounding investors expect when a dominant workflow asset continues to monetize through pricing and usage.
The franchise looks stable to improving on the data provided, but not without fragility. Revenue growth was +19.3% YoY and EPS growth was +29.8% YoY, which suggests the business is still expanding faster at the bottom line than at the top line. That is consistent with a score-based model that retains strong pricing power and incremental economics.
Operationally, the trend is supported by strong cash generation: FY2025 free cash flow was $769.885M, operating cash flow was $778.807M, and capex was only $8.9M. Those numbers imply that the franchise is not just growing, but doing so with very little reinvestment. The key caveat is that this trajectory depends on continued lender reliance; the data do not show market-share erosion, but they also do not provide a year-over-year share series, so the durability of the current position remains the central question.
Put differently, the trajectory is constructive because the economics are still compounding, but it is not “safe” in the sense of being diversified. The value driver remains concentrated in a single embedded standard, so the trend is only as good as lender adoption and the absence of meaningful score substitution.
The upstream inputs to this driver are lender adoption, underwriting workflow integration, regulatory acceptance, and the perceived superiority of the score in credit decisions. If lenders continue to depend on the score as a default decision layer, then FICO benefits from recurring usage and pricing power. The institutional survey’s 90% top-lender usage figure is the clearest sign that the score is deeply upstream in lending workflows.
Downstream, the franchise drives the company’s unusually strong economics: 46.5% operating margin, 38.7% FCF margin, and $651.9M net income in FY2025. Those cash flows support debt service on $3.20B of long-term debt and help justify the premium multiple. If this upstream adoption weakens, the downstream effects are immediate: lower revenue realization, compressed margin leverage, a lower valuation multiple, and a potentially much smaller equity value because the capital structure leaves limited room for error.
So the driver is not just a commercial metric; it is the bridge between distribution power and equity value. That is why score substitution risk matters more here than in a typical information-services business.
FICO’s current market value depends on the market’s belief that the score franchise remains structurally embedded. The deterministic DCF values the stock at $2,283.27 per share versus a live price of $1,063.33, while the reverse DCF implies the market is effectively discounting -3.6% growth and a 3.2% implied WACC. That tells us the stock is highly sensitive to assumptions around durability rather than near-term earnings alone.
Using the provided per-share economics as a bridge, each $1.00 change in EPS at today’s 40.1x P/E mechanically implies roughly $40.10 of stock value if the multiple is held constant. On the institutional estimate path, EPS rises from $29.91 in 2025 to $41.15 in 2026 and $52.50 in 2027; if that compounding is sustained and the market maintains a franchise-like multiple, the equity can justify materially higher prices. Conversely, if score usage weakens and the multiple compresses, the downside is amplified by the company’s negative equity and leverage-heavy balance sheet.
Bottom line: the valuation bridge is not a normal revenue-to-EV story. It is a franchise-quality story where market share, pricing power, and workflow entrenchment translate directly into EPS durability and multiple support.
| Metric | Value |
|---|---|
| Revenue growth | +19.3% |
| Revenue growth | +29.8% |
| Free cash flow | $769.885M |
| Free cash flow | $778.807M |
| Pe | $8.9M |
| Metric | Value | Why it matters |
|---|---|---|
| FICO Score usage among top lenders | 90% | Primary evidence of embedded market share… |
| Revenue per share (2024 → 2025) | $70.41 → $83.78 | Shows per-share monetization is still increasing… |
| EPS (2024 → 2025) | $20.45 → $29.91 | Signals faster earnings growth than revenue growth… |
| Operating margin (FY2025) | 46.5% | Indicates strong pricing power / low marginal cost… |
| Free cash flow margin (FY2025) | 38.7% | Shows conversion of earnings into cash |
| Long-term debt (2025-12-31) | $3.20B | High leverage increases sensitivity to franchise erosion… |
| Shareholders’ equity (2025-12-31) | -$1.81B | Residual equity cushion is negative |
| Current ratio | 0.93 | Liquidity is tight, though not distressed… |
| EV / EBITDA | 30.1x | Valuation assumes the moat remains intact… |
| Market price (2026-03-24) | $1,063.33 | Useful anchor versus DCF and scenario ranges… |
| Metric | Value |
|---|---|
| Top-lender usage | 90% |
| Operating margin | 46.5% |
| FCF margin | 38.7% |
| Net income | $651.9M |
| Of long-term debt | $3.20B |
| Factor | Current Value | Break Threshold | Probability | Impact |
|---|---|---|---|---|
| Top-lender usage | 90% | Below 80% | Low / medium | High: would call embedded-standard thesis into question… |
| Revenue growth YoY | +19.3% | Below 10% for multiple periods | MEDIUM | High: would signal demand/pricing deceleration… |
| EPS growth YoY | +29.8% | Below 10% | MEDIUM | High: would imply the operating leverage is fading… |
| Operating margin | 46.5% | Below 35% | MEDIUM | High: would indicate pricing pressure or mix deterioration… |
| FCF margin | 38.7% | Below 25% | MEDIUM | High: would weaken debt-service and valuation support… |
| Interest coverage | 8.8 | Below 5.0 | LOW | Very high: would raise refinancing concern… |
| Current ratio | 0.93 | Below 0.8 | LOW | Moderate: signals liquidity tightening |
1) Next earnings / guidance update — Probability: 80%. Estimated price impact: +$90 to +$180/share if revenue growth, EPS, and FCF conversion remain in line with 2025 strength. This is the highest-probability catalyst because earnings dates are recurring and the company already posted $26.54 diluted EPS, 29.8% EPS growth, and $769.885M free cash flow. The market’s key question is not whether FICO is profitable, but whether the current pace of monetization is durable enough to justify a premium multiple. If the company reports stable or improving guidance, the stock can re-rate quickly because current valuation embeds a lot of skepticism despite the strong cash profile.
2) Regulatory clarity on score pricing / access — Probability: 35%. Estimated price impact: -$75 to +$120/share depending on whether the message is restrictive or permissive. This is the most asymmetric catalyst because the downside is larger than the probability would suggest: any formal pressure on scoring economics could compress the multiple even if near-term earnings hold. Conversely, a benign policy backdrop would remove an overhang and support the thesis that the market is over-discounting durability. Evidence quality is mostly thesis-driven because the data spine does not include an actual forthcoming date; the catalyst remains real, but timing is uncertain.
3) Capital allocation / buyback update — Probability: 30%. Estimated price impact: +$25 to +$60/share if repurchases accelerate and leverage is portrayed as manageable. With long-term debt at $3.20B, cash at $162.0M, and interest coverage of 8.8, management has limited but meaningful flexibility to signal confidence via capital returns. The catalyst is smaller than earnings or regulation, but it can matter because the stock trades at 40.1x P/E and investors need evidence that earnings growth can continue to compound into per-share value creation.
The next two quarters should be judged on whether FICO can keep translating revenue growth into earnings and cash without any sign of customer pushback. The most important thresholds are: revenue growth staying near or above 15%, EPS growth staying above 20%, FCF margin staying above 35%, and interest coverage remaining above 8.0x. If the company can hold those levels while long-term debt stays contained relative to free cash flow, the market is likely to continue treating the leverage as manageable rather than threatening.
Watch current ratio as a liquidity stress indicator, because the latest value is only 0.93 and current liabilities are $752.1M versus cash of $162.0M. That does not imply distress today given $778.807M operating cash flow, but it does mean any guidance miss or cash conversion hiccup would be noticed quickly. The key thesis change would be a combination of slower revenue growth, weaker margin conversion, and rising debt balances; that would suggest the market is right to discount the stock more aggressively than the base DCF implies.
Major catalyst 1: Earnings and guidance. Probability of occurring: 80%. Expected timeline: next scheduled quarterly release within the next 1-2 quarters [exact date UNVERIFIED]. Evidence quality: Hard Data because the company has audited FY2025 results showing $924.9M operating income, $651.9M net income, and $769.885M free cash flow. If it does not materialize as a positive surprise, the stock likely trades on the existing premium multiple and could de-rate toward the Monte Carlo median of $967.12.
Major catalyst 2: Regulatory benignity. Probability of occurring: 35%. Expected timeline: within 12 months. Evidence quality: Thesis Only because the spine contains no dated agency action, only the obvious strategic sensitivity of the business to policy scrutiny. If it does not materialize, downside could be substantial because a headline-driven multiple compression could hit the stock by roughly -$75 to -$150/share even if fundamentals stay intact.
Major catalyst 3: Capital allocation / buyback support. Probability of occurring: 30%. Expected timeline: next 1-4 quarters. Evidence quality: Soft Signal since debt is elevated at $3.20B and equity is -$1.81B, but free cash flow and interest coverage suggest management has room to signal confidence. If it does not materialize, the thesis is not broken; the market simply keeps waiting for per-share compounding to do the heavy lifting. Overall value trap risk: Medium. The business is real and cash-generative, but the valuation can still stagnate if no catalyst resolves the durability debate.
| Date | Event | Category | Impact | Probability (%) | Directional Signal |
|---|---|---|---|---|---|
| 2026-04-?? | Next quarterly earnings release / guidance update | Earnings | HIGH | 80 | BULLISH |
| 2026-05-?? | Q2 2026 earnings / possible upward EPS revision | Earnings | HIGH | 65 | BULLISH |
| 2026-06-?? | Regulatory commentary on score pricing / consumer credit access | Regulatory | HIGH | 35 | BEARISH |
| 2026-07-?? | Mortgage / lending-cycle data inflection | Macro | MEDIUM | 50 | NEUTRAL |
| 2026-08-?? | Product roadmap update for decisioning / analytics suite | Product | MEDIUM | 45 | BULLISH |
| 2026-09-?? | Potential share repurchase / capital allocation update | M&A | LOW | 30 | BULLISH |
| 2026-10-?? | Q3 2026 earnings and full-year guidance refresh | Earnings | HIGH | 75 | BULLISH |
| 2026-11-?? | Federal policy or enforcement headline involving credit scoring | Regulatory | HIGH | 25 | BEARISH |
| 2026-12-?? | Year-end funding / consumer credit demand trends | Macro | MEDIUM | 55 | NEUTRAL |
| 2027-03-?? | Next fiscal-year annual report / capital structure update | Earnings | HIGH | 70 | BULLISH |
| Date/Quarter | Event | Category | Expected Impact | Bull/Bear Outcome |
|---|---|---|---|---|
| Q2 2026 | Quarterly earnings release / guidance | Earnings | High: first checkpoint on whether 2025 EPS momentum persists… | Bull: revenue and EPS hold above current run-rate; Bear: guidance implies deceleration… |
| Q2-Q3 2026 | Management commentary on score pricing and customer reaction… | Product | High: core monetization is the main thesis driver… | Bull: no evidence of pushback; Bear: slower pricing or customer substitution… |
| Q2-Q3 2026 | Regulatory headline risk around scoring access / consumer fairness… | Regulatory | High: could compress multiple if policy scrutiny rises… | Bull: no action / benign commentary; Bear: formal scrutiny or adverse rule proposals… |
| Q3 2026 | Lending-cycle read-through from mortgage, auto, and unsecured credit… | Macro | Med: demand mix and score volume sensitivity… | Bull: credit demand stabilizes; Bear: volume weakness offsets pricing… |
| Q3-Q4 2026 | Product / analytics suite updates and cross-sell… | Product | Med: supports multiple if growth broadens… | Bull: attach rates rise; Bear: product news is incremental only… |
| Q3-Q4 2026 | Capital allocation update / buyback pace… | M&A | Low-Med: earnings per share support | Bull: aggressive repurchases; Bear: leverage limits capital returns… |
| Q4 2026 | Full-year guidance reset | Earnings | High: defines next leg of valuation debate… | Bull: FY27 guide beats consensus; Bear: guide implies normalization… |
| Q4 2026 | Regulatory / political commentary into year-end… | Regulatory | High: headline risk can re-rate the stock quickly… | Bull: no material scrutiny; Bear: policy pressure on score economics… |
| Q1 2027 | Annual report and balance sheet review | Earnings | High: leverage, liquidity, and cash conversion update… | Bull: FCF covers debt growth; Bear: current ratio and debt metrics worsen… |
| Next 12 months | Potential strategic M&A or portfolio actions [speculative] | M&A | Low: optionality but not base case | Bull: accretive tuck-in or capital return; Bear: no deal, thesis unchanged… |
| Date | Quarter | Key Watch Items |
|---|---|---|
| 2026-04-?? | Q1 FY2026 | Revenue growth, EPS growth, FCF conversion, guidance… |
| 2026-07-?? | Q2 FY2026 | Pricing durability, score demand, margin stability… |
| 2026-10-?? | Q3 FY2026 | Credit-cycle read-through, debt service, buybacks… |
| 2027-01-?? | Q4 FY2026 | Full-year guidance, leverage, liquidity, cash conversion… |
| Parameter | Value |
|---|---|
| Revenue (base) | $2.0B (USD) |
| FCF Margin | 38.7% |
| WACC | 6.0% |
| Terminal Growth | 4.0% |
| Growth Path | 19.3% → 14.3% → 11.1% → 8.4% → 6.0% |
| Template | asset_light_growth |
| Revenue Growth Yoy | +19.3% |
| Free Cash Flow | $769.9M |
| Operating Margin | 46.5% |
| Implied Parameter | Value to Justify Current Price |
|---|---|
| Implied Growth Rate | -3.6% |
| Implied WACC | 3.2% |
| Implied Terminal Growth | 1.6% |
| Current Price | $1,063.33 |
| Current Enterprise Value | $28.25B |
| Current P/E | 40.1x |
| Component | Value |
|---|---|
| Beta | 0.30 (raw: -0.01, Vasicek-adjusted) |
| Risk-Free Rate | 4.25% |
| Equity Risk Premium | 5.5% |
| Cost of Equity | 5.9% |
| D/E Ratio (Market-Cap) | 0.13 |
| Dynamic WACC | 6.0% |
| Raw Regression Beta | -0.008 |
| Market Cap | $25.22B |
| Metric | Value |
|---|---|
| Current Growth Rate | 7.3% |
| Growth Uncertainty | ±14.6pp |
| Observations | 17 |
| Year 1 Projected | 6.3% |
| Year 2 Projected | 5.6% |
| Year 3 Projected | 5.0% |
| Year 4 Projected | 4.5% |
| Year 5 Projected | 4.1% |
| Latest Revenue Growth Yoy | +19.3% |
| Metric | 2023/2024 | 2025-09-30 | 2025-12-31 | Comment |
|---|---|---|---|---|
| Revenue | — | $374.4M | — | Latest full-year revenue is up +19.3% YoY. |
| Gross Margin | — | 14.1% | — | Low reported gross margin is offset by very high operating leverage. |
| Operating Margin | — | 46.5% | Latest annual operating income was $924.9M. | |
| EPS (Diluted) | — | $26.54 | $6.61 | YoY EPS growth was +29.8%; quarterly cadence normalized in Q4. |
| R&D % Rev | — | 9.5% | — | R&D remains a meaningful but controlled reinvestment load. |
| SG&A % Rev | — | 25.8% | — | Operating leverage remains strong despite ongoing sales and admin spend. |
| Peer Context | Equifax / Verisk | FICO materially above peers on profitability quality… | Broadridge | Peer metrics are not provided; comparison is qualitative only. |
| Net Margin | — | 32.7% | — | Net income reached $651.9M in the latest annual period. |
| Metric | 2024-12-31 | 2025-03-31 | 2025-12-31 | Assessment |
|---|---|---|---|---|
| Cash & Equivalents | $184.3M | $146.6M | $162.0M | Cash is adequate but not large versus debt. |
| Current Assets | $595.8M | $724.9M | $698.8M | Working capital is tight. |
| Current Liabilities | $331.3M | $343.2M | $752.1M | Current liabilities rose sharply in the latest quarter. |
| Long-Term Debt | $2.41B | $2.51B | $3.20B | Debt climbed materially across the period. |
| Shareholders' Equity | — | -$1.12B | -$1.81B | Book equity is deeply negative. |
| Current Ratio | — | 0.93 | 0.93 | Liquidity is below 1.0 and needs monitoring. |
| Interest Coverage | — | 8.8 | 8.8 | Coverage is acceptable, but leverage leaves less cushion. |
| Total Assets | $1.71B | $1.84B | $1.85B | Asset base remains modest relative to enterprise value. |
| Metric | Value | Context | Implication | Quality |
|---|---|---|---|---|
| Operating Cash Flow | $778.807M | Latest full-year period | Cash generation closely matches earnings scale… | STRONG |
| Free Cash Flow | $769.885M | Latest full-year period | FCF is nearly equal to OCF | STRONG |
| FCF Margin | 38.7% | Computed ratio | High conversion of revenue into free cash… | STRONG |
| CapEx | $8.9M | FY2025 | Very low reinvestment need | STRONG |
| CapEx / Revenue | 2.4% | $8.9M / $374.4M | Asset-light operating model | STRONG |
| D&A | $15.0M | FY2025 | CapEx below depreciation | Neutral |
| FCF / Net Income | 118.1% | $769.885M / $651.9M | Earnings are well supported by cash | STRONG |
| Working Capital | -$53.3M | $698.8M - $752.1M | Slight operating drag from liabilities | Watch |
| Metric | Value | Evidence | Assessment | Peer/Context |
|---|---|---|---|---|
| R&D % Revenue | 9.5% | Deterministic ratio | Meaningful reinvestment, not excessive | Below a 10% dilution-style concern threshold… |
| SBC % Revenue | 7.9% | Deterministic ratio | Manageable dilution burden | Below 10% warning threshold |
| Dividend | $0.00/share | Institutional survey | No cash returned via dividends | Retained for flexibility |
| Buybacks | — | Not provided in spine | Cannot assess price discipline | Material gap |
| M&A Track Record | — | Not provided in spine | No quantified deal history available | Material gap |
| Revenue/Share 2025 | $83.78 | Institutional survey | Per-share growth remains strong | vs $70.41 in 2024 |
| EPS 3-5Y Est. | $60.00 | Institutional survey | Signals confidence in long-duration compounding… | Survey-based, not audited |
| Target Range 3-5Y | $2,160.00-$3,240.00 | Institutional survey | Implied upside if execution persists | Survey-based, not audited |
| Line Item | FY2020 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Revenues | $374M | $1.4B | $1.5B | $1.7B | $2.0B |
| COGS | — | $302M | $311M | $348M | $354M |
| R&D | — | $147M | $160M | $172M | $188M |
| SG&A | — | $384M | $401M | $463M | $513M |
| Operating Income | — | $542M | $643M | $734M | $925M |
| Net Income | — | $374M | $429M | $513M | $652M |
| EPS (Diluted) | — | $14.18 | $16.93 | $20.45 | $26.54 |
| Op Margin | — | 39.4% | 42.5% | 42.7% | 46.5% |
| Net Margin | — | 27.1% | 28.4% | 29.9% | 32.7% |
| Category | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|
| CapEx | $6M | $4M | $9M | $9M |
| Component | Amount | % of Total |
|---|---|---|
| Long-Term Debt | $3.2B | 100% |
| Cash & Equivalents | ($162M) | — |
| Net Debt | $3.0B | — |
FICO’s 2025 cash profile shows an unusually asset-light model: $778.807M of operating cash flow, $8.9M of CapEx, and $769.885M of free cash flow. That makes the company capable of funding multiple uses of cash, but the balance sheet changes the order of operations. With $3.20B of long-term debt, $752.1M of current liabilities, and shareholders’ equity at - $1.81B, the most rational first claim on FCF is debt reduction or refinancing, not aggressive distributions.
Relative to peers in information services, FICO’s cash conversion is clearly strong, but the lack of dividends and the absence of disclosed buyback data suggest a more defensive capital allocation stance than a typical mature software compounder. In practical waterfall terms, we would rank cash uses as: 1) debt paydown / balance-sheet repair, 2) maintenance R&D and minimal CapEx, 3) opportunistic buybacks only when the stock trades materially below intrinsic value, 4) cash accumulation for refinancing flexibility. Until leverage moderates, buybacks should be viewed as conditional rather than automatic, and dividends remain off the table given the explicit $0.00 per share record in the supplied institutional survey.
For FICO, shareholder return is overwhelmingly a price-appreciation story because cash payouts are effectively absent. The institutional survey shows $0.00 dividends per share in 2025, 2026E, and 2027E, and the supplied spine provides no repurchase series to attribute buyback yield. That means the current TSR decomposition is dominated by the stock’s change in market value, which is particularly notable given the current price of $1,063.33 and market cap of $25.22B.
From a valuation standpoint, the equity is already discounting premium fundamentals: P/E 40.1, EV/EBITDA 30.1, and FCF yield 3.1%. Against that backdrop, management’s capital allocation matters mainly through balance-sheet risk control and the credibility of future buyback optionality. Compared with peers such as Equifax, Verisk, and Broadridge in the institutional survey, FICO’s return profile should be viewed as a high-quality, high-multiple compounder rather than a current cash-yield story.
| Year | Shares Repurchased | Avg Buyback Price | Intrinsic Value at Time | Premium/Discount % | Value Created/Destroyed |
|---|
| Year | Dividend/Share | Payout Ratio % | Yield % | Growth Rate % |
|---|---|---|---|---|
| 2021 | $0.00 | 0.0% | 0.0% | — |
| 2022 | $0.00 | 0.0% | 0.0% | 0.0% |
| 2023 | $0.00 | 0.0% | 0.0% | 0.0% |
| 2024 | $0.00 | 0.0% | 0.0% | 0.0% |
| 2025 | $0.00 | 0.0% | 0.0% | 0.0% |
| Deal | Year | Price Paid | ROIC Outcome | Strategic Fit | Verdict |
|---|
FICO’s operating profile is defined by a very wide spread between revenue growth and the cost base. In FY2025, revenue reached $1.99B, up +19.3% YoY, while operating income advanced to $924.9M and net income to $651.9M. That combination translates into a 46.5% operating margin and 32.7% net margin, which are exceptionally strong for an information services company. The latest quarterly numbers reinforce the durability of the model: FY2025 Q4 revenue was not provided in the spine, but the quarter still produced operating income of $234.0M and net income of $158.4M, indicating that the business remained highly profitable into year-end. Over the multi-year frame shown in the revenue chart, revenue moved from $1.51B in FY2023 to $1.72B in FY2024 and $1.99B in FY2025, a two-year increase of $480.0M. That is meaningful absolute expansion for a company already operating at scale.
What makes this more notable is the low level of capital intensity. CapEx was only $8.9M in FY2025, compared with operating income of $924.9M and free cash flow of $769.9M, producing a free cash flow margin of 38.7%. D&A was $15.0M in FY2025, also small relative to earnings power. The result is a business that can translate a large share of revenue into cash, which is a hallmark of asset-light analytics and decisioning software models. Compared with peers like Equifax, Verisk Analytics, and Broadridge Financial Solutions, the differentiator here is not only margin structure but also the efficiency with which each incremental dollar of revenue reaches the bottom line. The current operating picture suggests that FICO is still benefitting from strong pricing, resilient demand, and operating leverage, even as the balance sheet remains debt-heavy with negative equity of -$1.81B.
The current market price of $1,063.33 and market cap of $25.22B imply that investors are paying a premium multiple for these economics. Against FY2025 revenue of $1.99B, the computed EV/Revenue is 14.2x and EV/EBITDA is 30.1x, reinforcing that the stock is valued more like a durable compounder than a cyclical information vendor. That valuation can be justified only if FICO continues converting operating growth into sustained EPS expansion, and the latest data show exactly that: EPS of $26.54 and YoY EPS growth of +29.8%. The key question for fundamentals is therefore less about near-term profitability and more about whether this high-return model can remain intact under the existing capital structure and competitive dynamics.
Revenue has accelerated over the last several reported years, climbing from $1.51B in FY2023 to $1.72B in FY2024 and $1.99B in FY2025. That implies an increase of 13.9% from FY2023 to FY2024 and 15.7% from FY2024 to FY2025, based on the audited figures in the spine. The revenue bridge included in this pane shows the two-year expansion as being driven by a $200.0M step-up from FY2023 to FY2024 and another $270.0M step-up from FY2024 to FY2025. In other words, the business added $470.0M of annual revenue over two years, which is a strong result for a company already operating at roughly $1.5B of annual sales in the starting period. The table also shows earlier historical revenue points of $305.3M in FY2019, $298.5M in FY2019, $308.0M in FY2020, $313.7M in FY2020, and $374.4M in FY2020, illustrating that the company’s scale base has expanded materially over time even though the earlier labels are duplicated in the source spine.
From a fundamentals perspective, this trajectory matters because it indicates that growth has not relied on one isolated year. The combination of 2024 and 2025 gains supports the case that FICO’s pricing power and product utility are still strong enough to move the revenue base meaningfully upward. The company’s latest revenue per share is $83.78, versus $70.41 in 2024, and the institutional survey projects $102.50 in 2026 and $120.85 in 2027. Those per-share figures imply that revenue growth can continue even without a large share count increase, since shares outstanding were 23.8M at 2025-09-30 and 2025-12-31. That is important in a high-multiple stock where per-share compounding tends to matter more than top-line scale alone.
Against the peer set named in the institutional survey—Equifax, Verisk Analytics, Broadridge Financial Solutions, and Investment Su...—FICO appears to operate with a different revenue mix and a stronger margin profile, though the spine does not provide each peer’s exact financials. What can be said with certainty is that FICO’s current revenue growth of +19.3% YoY is paired with much faster EPS growth of +29.8% YoY, indicating operating leverage. When revenue grows faster than the cost base, especially in a software-and-analytics model, it usually shows up as expanding margins and stronger free cash flow. That is exactly what the FY2025 results show.
FICO’s margin profile is one of the clearest signals of fundamental strength in the pane. FY2025 operating margin was 46.5%, gross margin was shown in the KPI tile as 14.1%, and net margin was 32.7%. The input chart also shows operating margin progressing from 39.4% in FY2022 to 42.5% in FY2023, 42.7% in FY2024, and 46.5% in FY2025. That is an expansion of 7.1 percentage points over three years, which is substantial at the level of a company already generating nearly $2B of annual revenue. The cost structure underneath that margin performance is visible in the audited figures: R&D expense was $188.3M in FY2025, SG&A was $513.0M, and cost of revenue was $353.7M. Relative to revenue, those line items correspond to R&D/Revenue of 9.5%, SGA/Revenue of 25.8%, and the balance falling through to operating profit. This is a lean operating model by large-cap software standards.
The margin walk exhibit in the pane is directionally intended to show how gross margin changed between periods, but the labels are duplicated in the source. Even so, the underlying margin history in the spine still supports the broader conclusion: the company is sustaining high profitability while increasing scale. One of the most useful ways to think about this is to compare the absolute expense load versus the earnings base. For FY2025, SG&A of $513.0M and R&D of $188.3M together total $701.3M, which is still comfortably below operating income of $924.9M. That means the business can fund continued investment in product development and go-to-market while preserving a very large spread above operating costs. In an industry where peers such as Equifax and Verisk are also prized for recurring economics, FICO’s current margin levels place it in a premium tier.
There is also an important capital structure overlay. Negative shareholders’ equity of -$1.81B means accounting equity is not the right lens for judging operating quality here; leverage metrics and cash conversion are more relevant. Interest coverage of 8.8x indicates that operating income still covers financing costs at a comfortable level, but the long-term debt balance of $3.20B means margin durability matters. If margins were to compress materially, the market would likely reassess the valuation quickly. For now, though, the evidence still points to exceptional operating leverage and disciplined cost control. The recent trend suggests that management is extracting more earnings from each dollar of revenue, not less.
Cash generation is a core part of the FICO fundamentals story. The computed free cash flow in FY2025 was $769.9M, against operating cash flow of $778.8M and CapEx of only $8.9M. That means FCF margin was 38.7% and FCF yield was 3.1% at the current market capitalization, based on the live stock price of $1,063.33 and market cap of $25.22B. The limited capital intensity is evident in the CapEx series as well: CapEx was $3.0M in 2025-03-31 6M cumulative, $4.8M in 2025-06-30 9M cumulative, $8.9M for FY2025, and only $226.0K in the 2025-12-31 quarter. D&A likewise remained modest at $15.0M for FY2025. These figures are consistent with a software-like, asset-light economics model where earnings convert efficiently into cash.
The cash balance is not especially large relative to debt, but it is stable enough to support operations. Cash & equivalents were $134.1M at 2025-09-30 and $162.0M at 2025-12-31, while long-term debt increased from $3.06B to $3.20B over the same period. Current ratio remained below 1.0 at 0.93, indicating that short-term liquidity is tight on a balance sheet basis. That said, the business is not being evaluated like a capital-intensive industrial company; it is being evaluated as a high-cash-flow information services asset with meaningful financial leverage. In that framework, the combination of 8.8x interest coverage and near-$770M annual free cash flow remains supportive.
The key fundamental implication is that FICO has the ability to fund shareholder value creation through internal cash generation rather than heavy reinvestment. For a company with revenue per share of $83.78 and an institutional estimate of $102.50 in 2026, this matters because the per-share economics can continue improving even if the balance sheet stays debt-heavy. Investors should note, however, that FCF yield of 3.1% is not cheap in absolute terms for a company with this capital structure. The market is paying for durability, not merely for current cash flow. That leaves less room for disappointment if growth decelerates or if debt servicing becomes more constraining.
The balance sheet remains the most unusual part of the fundamentals picture. Total assets were $1.85B at 2025-12-31, while total liabilities were $3.66B, leaving shareholders’ equity at -$1.81B. Long-term debt rose from $2.41B at 2024-12-31 to $3.20B at 2025-12-31, and current liabilities increased from $331.3M to $752.1M across the same general period. Cash & equivalents were $184.3M at 2024-12-31, $146.6M at 2025-03-31, $189.0M at 2025-06-30, $134.1M at 2025-09-30, and $162.0M at 2025-12-31. Goodwill stayed relatively stable in the high-$700M range, ending at $783.5M in the latest interim period. Taken together, these figures show a company with substantial financial leverage but also with a stable operating asset base and a large earnings stream.
The most relevant liquidity metric in the spine is the current ratio of 0.93, which confirms that current liabilities exceed current assets. In a conventional industrial or retail setting that might be alarming, but for FICO the more important question is whether operating cash flow can comfortably support debt service and working capital needs. With operating cash flow of $778.8M and interest coverage of 8.8x, the answer appears to be yes for now. Still, the trajectory of liabilities is worth watching: total liabilities climbed from $2.84B at 2024-12-31 to $3.66B at 2025-12-31, a sizable increase over the reported intervals. That balance sheet expansion means the equity story depends heavily on continued profitability and free cash flow strength.
Peer comparison is useful here, even if the spine does not provide exact peer balance sheets. The institutional survey places FICO alongside Equifax, Verisk Analytics, and Broadridge Financial Solutions in the information services universe. Among those names, FICO stands out for its high return on assets of 35.2% and return on invested capital of 63.1%, which indicate that the business earns very strong returns on its asset base and capital structure. Negative book value per share in the institutional survey reinforces the point that book equity is not a useful valuation anchor. Instead, the market is effectively underwriting the ongoing monetization of FICO’s decisioning and scoring franchise, assuming that cash generation remains strong enough to service a balance sheet that is structurally more leveraged than peers.
| FY2023 | 1,510.0 | — | — | — | 42.5% | 28.4% |
| FY2024 | 1,720.0 | — | — | — | 42.7% | 29.9% |
| FY2025 | 1,990.0 | 924.9 | 651.9 | 26.54 | 46.5% | 32.7% |
| 2024-12-31 | 184.3 | 595.8 | 331.3 | 2,410.0 | 2,840.0 | — |
| 2025-03-31 | 146.6 | 724.9 | 343.2 | 2,510.0 | 2,960.0 | -1,120.0 |
| 2025-06-30 | 189.0 | 709.8 | 770.6 | 2,780.0 | 3,260.0 | -1,400.0 |
| 2025-09-30 | 134.1 | 705.2 | 849.2 | 3,060.0 | 3,610.0 | -1,750.0 |
| 2025-12-31 | 162.0 | 698.8 | 752.1 | 3,200.0 | 3,660.0 | -1,810.0 |
| 2024-12-31 | 0.841 | 3.5 | — | — | — |
| 2025-03-31 6M-CUMUL | 3.0 | 7.0 | — | — | — |
| 2025-06-30 9M-CUMUL | 4.8 | 10.9 | — | — | — |
| FY2025 | 8.9 | 15.0 | 778.8 | 769.9 | 38.7% |
| 2025-12-31 Q | 0.226 | 4.0 | — | — | — |
Using the Greenwald lens, this market is semi-contestable because FICO appears to have a dominant position in underwriting workflows, but the spine does not prove that competitors cannot replicate the cost structure or capture equivalent demand at the same price. The strongest evidence is the claim that FICO Scores are used by 90% of top lenders, alongside a 46.5% operating margin and very low capex intensity, which together imply a powerful incumbent seat.
However, the required moat test is incomplete: we do not have audited switching-cost data, renewal retention, customer concentration, or direct share-by-product data versus Equifax, Verisk, or other scoring alternatives. That means the market is not best treated as pure non-contestable monopoly territory; instead, it is a high-quality franchise where entry is hard, but not demonstrably impossible. The key question is not whether FICO is good, but whether rivals can persuade lenders to adopt an alternative score without unacceptable workflow, reputation, or compliance friction.
Conclusion: this market is semi-contestable because the incumbent has strong embedded demand and scale economics, but the evidence package does not yet show fully insurmountable barriers to entry.
FICO’s economics look highly scalable, but the durability of that advantage depends on whether scale is paired with customer captivity. The evidence says CapEx was only $8.9M for 2025-09-30 while free cash flow was $769.885M, which is classic low-capital-intensity software economics. R&D was 9.5% of revenue and SG&A was 25.8% of revenue, suggesting a meaningful fixed-cost base that can be spread across additional volume.
The key Greenwald question is whether a hypothetical entrant at 10% market share could match the incumbent’s cost structure. On the spine, we do not have a direct minimum efficient scale estimate, but the available data imply the entrant would likely need substantial fixed investment in data, model development, compliance, and distribution before reaching comparable economics. Still, scale alone is not enough: if a lender could swap in a different score at the same price and retain similar underwriting outcomes, the entrant could eventually replicate the cost curve. That is why the interaction of scale and captivity is the moat, not scale by itself.
Bottom line: the business appears to have high fixed-cost leverage and very low ongoing capex, but the moat remains strongest only if that scale is coupled with sticky lender workflows and reputation-based trust.
This is N/A — company already has position-based CA on the best evidence available, because the economics are already showing up in high operating margin (46.5%), high ROIC (63.1%), and an unusually low CapEx footprint ($8.9M for 2025-09-30). The strategic question is therefore not whether management can convert a learning curve into a moat, but whether it can defend and deepen an already-advantaged position.
That said, management does appear to be doing the right things if the franchise is under pressure: the findings mention UltraFICO and FICO Score 10, which suggests product refresh and defense of the core. What is missing is direct evidence that these launches are expanding customer captivity through ecosystem lock-in, contractual integration, or materially higher switching costs. If future filings show lender migration to these products, renewal persistence, or evidence of broader platform embedding, that would strengthen the position-based classification further; if not, the edge remains commercially strong but partially exposed to contestability.
Pricing in this industry should be read less as a list price and more as a signal of willingness to defend the franchise. The spine does not provide direct evidence of a named price leader, but the economics imply that a dominant incumbent can set reference points for lenders and package pricing. That matters because in markets like this, a small move can communicate whether management wants to hold the line or defend share.
Using Greenwald’s framework, the most important question is whether rivals can observe, punish, and then reset pricing. We do not have documented episodes like BP Australia’s gradual price experiments or the Philip Morris vs. RJR punishment-and-return-to-cooperation cycle in the current data, so any claim of tacit collusion would be speculative. Still, the combination of high margins, embedded workflows, and long-lived customer relationships suggests that if FICO adjusts pricing, competitors are likely to notice quickly and interpret it as a signal about willingness to defend the base. If a defection episode occurred, the path back to cooperation would likely involve selective discounting or product bundling rather than broad, industry-wide list price cuts.
Interpretation: price is plausibly functioning as communication here, but the current evidence base is insufficient to prove a stable tacit pricing regime.
FICO appears to hold a privileged position in credit scoring and lender workflows, but the exact market share trend is not audited in the spine. The closest quantitative proxy is the claim that FICO Scores are used by 90% of top lenders, which implies a very broad installed base and suggests share is likely stable to gaining in the most important end-market. That said, this is still an evidence claim rather than a verified market-share series, so it should be treated as directional, not definitive.
The financial picture supports market position strength: revenue growth was +19.3%, EPS growth was +29.8%, and operating margin was 46.5%. Those numbers are hard to reconcile with a business that is losing relevance, especially when capex is only $8.9M and free cash flow is $769.885M. The right inference is that the company is monetizing a strong position; the unresolved question is whether that position is a durable standard or a highly profitable but contestable workflow layer.
The most important moat is not any single barrier in isolation; it is the interaction between customer captivity and economies of scale. FICO’s economics show both ingredients in partial form: a likely embedded presence in lender workflows, plus a very high operating margin of 46.5% and tiny annual CapEx of $8.9M. Those factors suggest the company can spread fixed costs over a large installed base while keeping incremental investment low.
The barriers become more persuasive if a hypothetical entrant cannot capture equivalent demand at the same price. The current spine does not provide measured switching costs in dollars or months, nor does it give a regulatory approval timeline or minimum investment threshold for entry, so the moat cannot be treated as fully quantified. If a competing score could be adopted by lenders without material revalidation, retraining, or workflow disruption, barriers would be weaker than the margin profile suggests. If, instead, model governance, historical performance trust, and underwriting policy integration create months of friction, then the barriers are materially stronger than the raw financials alone imply.
Bottom line: barriers are meaningful, but the strongest defense is the combined effect of scale and captivity, not scale alone.
| Metric | FICO | Equifax | Verisk Analytics | Broadridge Financial |
|---|---|---|---|---|
| Potential Entrants | Category | Potential entrants include bureau data platforms, fintech scoring vendors, and large analytics/software firms such as Experian, TransUnion, Oracle, or cloud-native underwriting tool providers. They face entrenched workflow integration, reputation risk in experience goods, and likely long sales cycles; exact regulatory approval timelines are . | Entry barrier | Customer captivity plus scale economics in lender workflows; the spine does not provide a measured minimum investment or approval timetable. |
| Buyer Power | Assessment | Buyers are primarily lenders and financial institutions; concentration by customer segment is . The 90% top-lender usage claim implies some dependency on FICO, which lowers buyer leverage, but the absence of audited switching-cost data means buyer power cannot be dismissed. | Switching costs from buyer's perspective… | Meaningful in workflow terms if models, governance, and underwriting policies are embedded, but exact dollar/month costs are not provided in the spine. |
| Mechanism | Relevance | Strength | Evidence | Durability |
|---|---|---|---|---|
| Habit Formation | Relevant | MODERATE | Score usage embedded in recurring lender underwriting workflows; repetitive use can become default behavior, but no frequency metric is audited. | Moderate to High |
| Switching Costs | Highly relevant | MODERATE | The 90% top-lender usage claim suggests workflow embeddedness, but the spine lacks direct data on migration cost, retraining, or policy revalidation burden. | High if workflows are truly embedded; unproven in spine… |
| Brand as Reputation | Relevant | STRONG | Credit scoring is an experience/trust good; lenders rely on a score with a long track record, and the franchise appears to benefit from reputation for reliability. | HIGH |
| Search Costs | Relevant | MODERATE | Underwriting tools and score alternatives are complex to compare, especially when compliance and model governance matter. | Moderate to High |
| Network Effects | Limited relevance | WEAK | This is not a classic two-sided marketplace; user value does not clearly rise with lender count in the way a platform would. | LOW |
| Overall Captivity Strength | Weighted assessment | MODERATE | Strong brand/reputation plus meaningful search/switching frictions, but no audited proof of lock-in or customer stickiness duration. | Moderate to High |
| Dimension | Assessment | Score (1-10) | Evidence | Durability (years) |
|---|---|---|---|---|
| Position-Based CA | Strong but not fully proven | 8 | 90% top-lender usage claim; 46.5% operating margin; 38.7% FCF margin; low CapEx indicate a potentially durable protected position, but direct switching-cost evidence is absent. | 5-10 |
| Capability-Based CA | Present but secondary | 6 | Strong operating execution and high ROIC (63.1%) suggest organizational and analytical capability; however, learning-curve advantages may be portable over time. | 2-5 |
| Resource-Based CA | Meaningful | 6 | Embedded score franchise, reputation, and likely data/model assets act like quasi-resource advantages; no patent/license exclusivity is provided in the spine. | 3-7 |
| Overall CA Type | Position-Based with capability support | 8 | The combined signal is workflow embeddedness plus scale economics; that is the strongest classification available from the spine, though still semi-contestable. | 5-10 |
| Factor | Assessment | Evidence | Implication |
|---|---|---|---|
| Barriers to Entry | Favors cooperation | 90% top-lender usage claim, low CapEx, and embedded workflow relevance suggest entry is hard, but not proven impossible. | External price pressure is reduced, which helps tacit coordination if rivals exist. |
| Industry Concentration | Mixed / incomplete | The spine names multiple peers but provides no HHI or product share series; direct concentration in score services is unverified. | Without concentration data, coordination stability cannot be quantified. |
| Demand Elasticity / Customer Captivity | Favors cooperation | Customer captivity appears moderate-to-strong due to workflow embeddedness and reputation; undercutting may not win much volume quickly. | Higher inelasticity makes price wars less attractive. |
| Price Transparency & Monitoring | Unclear | No evidence in the spine on whether competitor pricing is public, contractual, or negotiated case-by-case; many lender relationships are likely opaque. | Harder monitoring weakens tacit collusion stability. |
| Time Horizon | Favors cooperation | The franchise appears to be a long-duration business with recurring usage and strong cash generation rather than a shrinking market. | Patient players are more willing to sustain stable pricing. |
| Conclusion | Semi-stable cooperation | Strong barriers and inelastic demand support stable pricing, but missing concentration and transparency data prevent a full cooperation call. | Industry dynamics favor cooperation more than outright price warfare, but the equilibrium is not proven durable. |
| Factor | Applies (Y/N) | Strength | Evidence | Implication |
|---|---|---|---|---|
| Many competing firms | Y | MEDIUM | Multiple peers are named in the spine, but direct score-market concentration is not provided. | Harder to monitor and punish defection; cooperation less stable. |
| Attractive short-term gain from defection… | Y | HIGH | If demand is contestable, a price cut could win lender share quickly because the product is central to underwriting. | Raises risk of price warfare if rivals see near-term share gains. |
| Infrequent interactions | N | LOW | Lender relationships and scoring usage appear recurring rather than project-based, though exact contract cadence is unverified. | Supports repeated-game discipline and tacit coordination. |
| Shrinking market / short time horizon | N | LOW | Revenue growth was +19.3% and the business still appears to be expanding, not shrinking. | Longer horizon makes cooperation more valuable. |
| Impatient players | N | LOW | No distress signal from management incentives is provided; however, leverage is high and could increase impatience under pressure. | Lower current risk, but leverage could amplify impatience in a downturn. |
| Overall Cooperation Stability Risk | Y | MEDIUM | Strong embedded demand supports cooperation, but contestability and missing concentration data leave room for defections. | Pricing stability is plausible but not guaranteed. |
The supplied spine does not include a directly audited market-size study for FICO, so the most defensible bottom-up framework is to size the opportunity from observable monetization inputs rather than invent an industry TAM. The current audited revenue base is $374.4M, revenue growth is +19.3% YoY, and revenue per share increased from $70.41 in 2024 to $83.78 in 2025, indicating the business is already converting a large amount of economic value from a fixed 23.8M share base.
For a true bottom-up TAM, the missing inputs would be customer counts, license counts, pricing tiers, usage volumes, and revenue by product or geography. Without those, the best we can do is model served market penetration as a relative concept: high operating margin at 46.5%, net margin at 32.7%, and ROIC at 63.1% imply strong monetization efficiency, but they do not reveal how much of the underlying market has been captured. Any precise TAM dollar figure would therefore be speculative and is intentionally left unfilled rather than fabricated.
On the available evidence, FICO appears to be a highly penetrated monetizer within a still-expandable market, not a company whose reach can be measured from disclosed share data. The most relevant proxy is revenue per share, which moved from $70.41 in 2024 to $83.78 in 2025, while the institutional survey projects $102.50 in 2026 and $120.85 in 2027. That trajectory suggests continued ability to deepen monetization without requiring share count expansion.
Runway looks credible because the business generates $769.885M of free cash flow with only $8.9M of annual capex, so growth is capital-light and can be funded internally. The key limitation is that the spine contains no customer-count or wallet-share data, and the only geographic clue is a non-EDGAR claim that FICO operates in 90+ countries. That makes saturation risk hard to quantify, but it also means the bull case depends on continued adoption and pricing power rather than on a measured, auditable whitespace map.
| Segment | Current Size | CAGR |
|---|---|---|
| Company revenue base | $374.4M | +19.3% |
| Metric | Value |
|---|---|
| TAM | $374.4M |
| Revenue | +19.3% |
| Revenue | $70.41 |
| Revenue | $83.78 |
| Pe | 46.5% |
| Operating margin | 32.7% |
| Net margin | 63.1% |
| Metric | Value |
|---|---|
| Revenue | $70.41 |
| Revenue | $83.78 |
| Fair Value | $102.50 |
| Fair Value | $120.85 |
| Free cash flow | $769.885M |
| Free cash flow | $8.9M |
FICO’s technology story is unusually strong at the economics level, but weakly disclosed at the architecture level. The company produced $924.9M of operating income in 2025 on $353.7M of cost of revenue and only $188.3M of R&D expense, which implies a proprietary stack that monetizes efficiently without requiring heavy infrastructure or constant reinvention. In practice, that points to software-like economics, data/model leverage, and embedded workflows, but the spine does not directly identify the product architecture, deployment model, or cloud migration path.
What is likely proprietary, based on the economics, is the decisioning logic and analytics embedded in customer processes; what is likely commodity is the underlying hosting, generic data plumbing, and standard enterprise integration layers. The evidence is not sufficient to quantify integration depth, so the moat thesis should be framed as an inference from operating performance rather than a disclosed technical fact. The key risk is that strong margins can mask architectural fragility until a competitor or a platform shift forces a re-platforming cycle.
The supplied data show a meaningful but controlled innovation budget: FICO spent $188.3M on R&D in 2025, equal to 9.5% of revenue. That level of spend is consistent with ongoing model refreshes, feature extensions, and maintenance of a high-value analytics platform, but the spine does not disclose named programs, product stages, beta releases, or launch timing. As a result, the pipeline must be assessed as an investment input rather than a visible catalog of upcoming products.
For planning purposes, the best-supported conclusion is that the company is funding incremental product improvement rather than a high-burn, venture-style innovation push. The absence of disclosed launch dates or revenue-at-risk metrics makes it impossible to assign precise product-by-product uplift; therefore, any estimate of incremental revenue impact should be treated as an analyst assumption. Given the 46.5% operating margin and $769.885M of free cash flow, FICO has ample internal capacity to fund roadmap work without pressuring the P&L.
The moat appears economically real, but the evidence set does not provide a patent schedule or an IP asset count. The company’s 2025 economics—46.5% operating margin, 63.1% ROIC, and 100 earnings predictability in the independent survey—are consistent with durable know-how, proprietary models, and customer embeddedness. However, because the spine lacks direct patent, trade-secret, or litigation disclosures, the defensibility claim remains partly inferential rather than fully proven.
From a protection-duration perspective, the most credible source of moat is likely trade secrets, model calibration, workflow integration, and customer process dependency rather than patent exclusivity alone. That matters because patent life is finite, while operationally embedded analytics can last much longer if the product remains embedded and refreshed. If the company ever disclosed a patent portfolio, model IP coverage, or customer renewal structure, this assessment could move from inferred durability to evidenced durability.
FICO looks like a premium product franchise on the basis of outcomes, not disclosures. The 2025 financial profile—46.5% operating margin, 38.7% FCF margin, $769.885M of free cash flow, and 9.5% R&D intensity—supports a thesis of a highly scalable, data- and model-driven business with meaningful operating leverage. At the same time, the supplied source set leaves the most important product questions unanswered: portfolio segmentation, launch cadence, architecture, patent coverage, and customer switching costs are all either missing or unverified. For an investor, that means the economics are compelling enough to keep the name on the long list, but conviction should rise only if future filings or disclosures make the moat explicit rather than inferred.
| Product / Service | Revenue Contribution ($) | % of Total | Growth Rate | Lifecycle Stage | Competitive Position |
|---|---|---|---|---|---|
| CORE FICO portfolio overall | $1990.9M | 100.0% | +19.3% | MATURE | Leader |
| CORE Decisioning / scoring platform | — | — | — | MATURE | Leader |
| CORE Analytics / optimization software | — | — | — | GROWTH | Challenger |
| CORE Platform / API-enabled services | — | — | — | GROWTH | Leader |
| SUPPORT Implementation / support services | — | — | — | MATURE | Niche |
| NONCORE Legacy / non-core offerings | — | — | — | DECLINE | Niche |
| Metric | Value |
|---|---|
| Operating margin | 46.5% |
| Operating margin | 63.1% |
| Fair Value | $769.885M |
| Fair Value | $783.5M |
FICO does not provide a disclosed supplier concentration table in the supplied EDGAR spine, so no named vendor can be assigned a verified revenue dependency percentage. That said, the operating model itself strongly implies concentration in a small set of mission-critical service inputs rather than a broad physical procurement base. The clearest evidence is that quarterly cost of revenue remained tightly clustered at $87.6M, $87.6M, and $87.3M in 2025, even as revenue growth accelerated to +19.3% YoY.
From a risk standpoint, the real single points of failure are likely cloud hosting, data licensing, and internal delivery infrastructure, but those dependencies are because the filing set does not identify vendors or usage shares. The implication for investors is not that concentration is low, but that concentration risk is unobserved: the company can look operationally smooth while still depending on a narrow group of service providers. If one of those providers were interrupted, the impact would likely show up first in delivery latency, client onboarding, or support performance rather than in inventory shortages.
There is no disclosed sourcing-region or facility-country breakdown, so geographic exposure cannot be quantified with audited percentages. That said, the business profile is consistent with a digitally delivered information-services platform, which makes the operational footprint more dependent on data centers, offices, and network connectivity than on ports, factories, or shipment lanes. The company’s very low CapEx of $8.9M for FY2025 reinforces the view that its supply chain is asset-light and likely service-based rather than manufacturing-based.
Because no geographic mix is available, tariff exposure, single-country dependence, and cross-border supplier concentration are all . Investors should therefore treat geographic risk as a hidden sensitivity rather than a demonstrated weakness. If a future filing shows heavy reliance on a single U.S. cloud region or an offshore development center, the current risk score would need to be revised materially upward; absent that disclosure, the best-supported view is that FICO’s geographic risk is moderate but not measurable.
| Component/Service | Substitution Difficulty (Low/Med/High) | Risk Level (Low/Med/High/Critical) | Signal (Bullish/Neutral/Bearish) |
|---|---|---|---|
| Cloud hosting / infrastructure | HIGH | HIGH | NEUTRAL |
| Data licensing / bureau feeds | HIGH | HIGH | NEUTRAL |
| Software development tools / DevOps | MEDIUM | MEDIUM | NEUTRAL |
| Customer support / service delivery vendors… | MEDIUM | MEDIUM | NEUTRAL |
| Cybersecurity / monitoring services | MEDIUM | MEDIUM | BULLISH |
| Enterprise software licenses | LOW | LOW | BULLISH |
| Professional services / implementation | LOW | LOW | NEUTRAL |
| Payments / treasury / banking services | LOW | MEDIUM | NEUTRAL |
| Telecom / network connectivity | LOW | MEDIUM | BULLISH |
| Customer | Revenue Contribution | Contract Duration | Renewal Risk | Relationship Trend (Growing/Stable/Declining) |
|---|
| Component | Trend (Rising/Stable/Falling) | Key Risk |
|---|---|---|
| Cloud hosting / infrastructure | Stable | Outage or pricing step-up could pressure delivery margins… |
| Data licensing / external feeds | Stable | Renewal pricing or exclusive-data dependence… |
| Personnel / engineering labor | Rising | Competition for talent could lift service costs… |
| Customer support / implementation | Stable | Higher service intensity during new deployments… |
| Cybersecurity / compliance tooling | Rising | Security incidents could disrupt service continuity… |
| Telecom / connectivity | Stable | Localized network interruption |
| Professional services / contractors | Falling | Execution bottlenecks if insourced too aggressively… |
| Depreciation & amortization | Stable | Reflects a light asset base; not a physical bottleneck… |
STREET SAYS FICO deserves a premium multiple because earnings quality is exceptional and the model converts efficiently: fiscal 2025 EPS was $26.54, operating margin was 46.5%, and net margin was 32.7%. The market is effectively paying for durability, not scale, with the share price at $1,063.33 and EV/EBITDA at 30.1.
WE SAY the upside is real, but timing is less straightforward than the valuation gap suggests. Our base DCF value is $2,283.27, implying roughly +114.6% upside versus the current price, yet the balance sheet is materially constraining with total liabilities of $3.66B, shareholders’ equity of -$1.81B, and current ratio of 0.93. In other words, the thesis is still Long on compounding, but we think the Street may be underweighting the importance of leverage normalization before the multiple fully rerates.
Direction: The available evidence suggests revisions are more likely to be upward in EPS than in revenue, but the actual analyst revision history is not supplied and must be treated as . The strongest hard datapoint is that audited diluted EPS reached $26.54 in fiscal 2025, while the independent institutional survey points to $29.91 for 2025, $41.15 for 2026, and $52.50 for 2027.
Driver: The revisions case is being driven by operating leverage rather than top-line acceleration. Operating margin is 46.5% and free cash flow is $769.885M, so even modest revenue/share growth can translate into outsized EPS growth; however, the increase in long-term debt to $3.20B and current ratio of 0.93 likely keeps some analysts cautious on target multiple expansion.
DCF Model: $2,283 per share
Monte Carlo: $967 median (10,000 simulations, P(upside)=45%)
Reverse DCF: Market implies -3.6% growth to justify current price
| Metric | Value |
|---|---|
| EPS | $26.54 |
| EPS | 46.5% |
| Operating margin | 32.7% |
| EV/EBITDA | $1,063.33 |
| DCF | $2,283.27 |
| DCF | +114.6% |
| Fair Value | $3.66B |
| Fair Value | $1.81B |
| Metric | Street Consensus | Our Estimate | Diff % | Key Driver of Difference |
|---|---|---|---|---|
| EPS (FY2025) | $29.91 | $26.54 | -11.3% | Independent survey EPS exceeds audited diluted EPS; we anchor to EDGAR-reported 26.54. |
| EPS (FY2026) | $41.15 | $41.15 | 0.0% | Institutional survey estimate used as cross-check; no separate Street consensus supplied. |
| Revenue/Share (FY2025) | $83.78 | $83.78 | 0.0% | Institutional survey per-share revenue used as reference since revenue consensus is unavailable. |
| Operating Margin | — | 46.5% | — | Computed ratio from authoritative data spine. |
| Gross Margin | — | 14.1% | — | Computed ratio suggests low gross margin but strong operating leverage. |
| Net Margin | — | 32.7% | — | Computed ratio from authoritative data spine. |
| Year | Revenue Est | EPS Est | Growth % |
|---|---|---|---|
| 2025 | $83.78 per share | $26.54 | +19.3% revenue growth / +29.8% EPS growth… |
| 2026 | $102.50 per share | $26.54 | +22.4% revenue/share growth / +37.6% EPS growth… |
| 2027 | $120.85 per share | $26.54 | +17.9% revenue/share growth / +27.6% EPS growth… |
| Firm | Analyst | Rating | Price Target | Date of Last Update |
|---|
| Metric | Current |
|---|---|
| P/E | 40.1 |
| P/S | 12.7 |
| FCF Yield | 3.1% |
FICO’s valuation is highly sensitive to discount rates because the business produces large, long-duration cash flows from a capital-light model. The deterministic DCF implies a per-share fair value of $2,283.27 at a 6.0% WACC and 4.0% terminal growth, while the reverse DCF says the current market price of $1,063.33 is consistent with only -3.6% implied growth and a 3.2% implied WACC. That spread tells us the stock behaves like a long-duration asset whose value can re-rate sharply if rates or the equity risk premium fall.
Balance-sheet structure makes this more important, not less. Long-term debt rose to $3.20B at 2025-12-31, total liabilities reached $3.66B, and shareholders’ equity was -$1.81B; despite that, interest coverage remains 8.8x, so the near-term refinancing risk is manageable, but the equity is still levered to credit-market sentiment. A 100bp increase in discount rate would be most damaging through the equity duration channel rather than through operating impairment: the market already discounts FICO as a skeptical long-duration compounder, so a higher rate environment would disproportionately pressure the present value of future cash generation.
FICO’s operating model is structurally insulated from commodity inflation relative to manufacturing or consumer discretionary businesses. The company posted only $8.9M of capex in 2025 and $226.0K in Q4 2025, which underscores a software/analytics cost structure rather than a materials-intensive one. The Data Spine does not disclose any meaningful input commodities, so direct COGS sensitivity to oil, metals, paper, or freight is .
That said, the absence of disclosed commodity exposure is itself informative: the important margin risk is not raw materials, but labor and cloud/infrastructure costs embedded in R&D and SG&A. In 2025, R&D was $188.3M and SG&A was $513.0M, so even a small inflation pulse in services or hosting costs could pressure operating leverage if revenue growth slows. The business likely has strong pass-through ability because of its pricing power and high margins, but the exact pricing response is not disclosed in the Data Spine.
Trade policy appears to be a second-order issue for FICO based on the available data. The Data Spine contains no disclosed tariff exposure by product or region, no China supply-chain dependency, and no import-sensitive COGS breakdown, so the direct margin impact from tariffs is . For a software and analytics company, the more plausible trade-policy channel would be indirect: slower enterprise spending if tariffs tighten financial conditions or reduce client IT budgets.
Because the company’s value proposition is driven by intellectual property, recurring analytics usage, and low physical-asset intensity, the core business should be less exposed than hardware-oriented peers. But the valuation multiple is high—P/E 40.1 and EV/EBITDA 30.1—so even a small revenue interruption matters. In a severe tariff scenario, the real damage would likely come from delayed enterprise deals and higher credit spreads rather than from direct cost inflation.
FICO’s demand sensitivity is better understood through credit and enterprise decision cycles than through direct household consumption. The Data Spine does not provide correlation coefficients to consumer confidence, GDP, or housing starts, so precise revenue elasticity is . Still, the company’s latest audited year shows revenue growth of 19.3% and EPS growth of 29.8%, which suggests the franchise can still compound even without a booming consumer backdrop.
The more relevant macro input is likely lending activity and score-usage intensity, which tend to track broader credit conditions. With operating margin at 46.5% and FCF margin at 38.7%, FICO does not need explosive volume growth to expand value; it needs stable enterprise demand and pricing discipline. In a slowdown, the company should hold up better than cyclical software, but a prolonged credit contraction would probably slow deal flow and push the valuation toward the Monte Carlo median of $967.12 rather than the DCF base case.
| Metric | Value |
|---|---|
| DCF | $2,283.27 |
| DCF | $1,063.33 |
| Implied growth | -3.6% |
| Fair Value | $3.20B |
| Fair Value | $3.66B |
| Fair Value | $1.81B |
| Free cash flow | $769.885M |
| Free cash flow | 38.7% |
| Region | Revenue % from Region | Primary Currency | Hedging Strategy | Net Unhedged Exposure | Impact of 10% Move |
|---|
| Indicator | Current Value | Signal | Impact on Company |
|---|---|---|---|
| Fed Funds Rate | 4.25% | NEUTRAL | Current policy is supportive of earnings quality but still constrains long-duration valuation… |
| Metric | Value |
|---|---|
| Capex | $8.9M |
| Capex | $226.0K |
| R&D was | $188.3M |
| SG&A was | $513.0M |
FICO’s earnings quality looks strong on the cash side and less clean on the balance sheet. The deterministic outputs show $778.807M of operating cash flow and $769.885M of free cash flow in FY2025, with an FCF margin of 38.7% and minimal capital intensity: CapEx was only $8.9M for FY2025 and $226.0K in the latest quarter. That is exactly the kind of conversion profile that supports a premium multiple if it proves durable across cycles.
At the same time, the balance sheet is not pristine and that matters for earnings quality interpretation. Total liabilities reached $3.66B at 2025-12-31 against total assets of $1.85B, leaving shareholders’ equity at -$1.81B. In other words, the earnings engine is real, but it sits inside a highly levered capital structure. There is no evidence here of a major one-time restructuring charge distorting the latest quarter, but the structural leverage means the reported profit stream must keep throwing off cash to remain credible. The latest quarter’s operating income of $234.0M and net income of $158.4M confirm the business is still generating earnings, though the data spine does not provide enough detail to isolate accruals versus cash-based earnings adjustments quarter by quarter.
The spine does not include 90-day analyst revision history, estimate snapshots, or consensus changes, so the actual direction and magnitude of revisions are . That is an important limitation because FICO is a valuation-sensitive compounder: even a small upward revision in EPS can support multiple expansion, while a small cut can compress the stock quickly when the shares are already priced at 40.1x earnings and 30.1x EBITDA.
What we can say is that the surrounding evidence is constructive: FY2025 EPS was $26.54, the institutional survey shows a 2025 EPS estimate of $29.91, and the 3-5 year EPS estimate rises to $60.00. That tells us the longer-horizon analyst frame is still pointing up, even though the near-term revision tape itself is missing. In practical terms, the next revision cycle should matter more than normal because the market is already pricing a meaningful amount of skepticism into the shares relative to the DCF base case of $2,283.27.
Based on the available audited numbers, management appears operationally credible because the company is still producing sizable profits and cash flow. FY2025 delivered $924.9M of operating income, $651.9M of net income, and $769.885M of free cash flow, while the latest quarter still posted $234.0M of operating income and $158.4M of net income. That is not the profile of a business in operational distress, and the institutional survey’s 100 earnings predictability score reinforces the idea that the earnings stream is unusually consistent.
However, credibility around explicit promises cannot be fully assessed because the spine provides no management guidance ranges, no beat/miss cadence versus consensus, and no restatement or goal-post-moving history. For that reason, the most defensible verdict is Medium-High credibility on execution, but unverified on formal guidance accuracy. If future filings show repeated upward guidance resets without a corresponding change in fundamentals, or if debt keeps climbing faster than cash generation, that assessment would need to be downgraded. Conversely, stable leverage and continued conversion of earnings to cash would strengthen the case that management is conservative and reliable rather than merely benefiting from favorable operating leverage.
The next quarter should be judged primarily on whether FICO can preserve its exceptional cash conversion while keeping leverage under control. The most recent audited quarter ended 2025-12-31 with $6.61 diluted EPS, $234.0M of operating income, and $158.4M of net income, so the business remains comfortably profitable. Because the spine does not include consensus estimates for the next quarter, our near-term estimate must be framed around the current run-rate: if operating income remains in the low-to-mid $200M range and cash flow stays strong, the market is likely to focus more on leverage than on a minor EPS wiggle.
The single datapoint that matters most is whether free cash flow continues to cover the debt burden without a noticeable deterioration in liquidity. The latest current ratio is 0.93, cash is only $162.0M, and long-term debt has increased to $3.20B. In our view, the market will tolerate a modest EPS miss if cash generation remains intact, but it would punish any evidence that the company is funding growth or buybacks through additional leverage. For that reason, the best next-quarter read-through is not just EPS versus some unavailable consensus number; it is whether operating cash flow and balance-sheet discipline remain aligned with the company’s premium valuation.
| Period | EPS | YoY Change | Sequential |
|---|---|---|---|
| 2023-03 | $26.54 | — | — |
| 2023-06 | $26.54 | — | +27.0% |
| 2023-09 | $26.54 | — | +233.3% |
| 2023-12 | $26.54 | — | -71.6% |
| 2024-03 | $26.54 | +29.0% | +7.5% |
| 2024-06 | $26.54 | -0.6% | -2.1% |
| 2024-09 | $26.54 | +20.8% | +305.0% |
| 2024-12 | $26.54 | +27.9% | -70.0% |
| 2025-03 | $26.54 | +27.7% | +7.3% |
| 2025-06 | $26.54 | +46.5% | +12.3% |
| 2025-09 | $26.54 | +29.8% | +258.6% |
| 2025-12 | $26.54 | +7.7% | -75.1% |
| Quarter | EPS Actual | Revenue Actual | Stock Move |
|---|---|---|---|
| FY2025 | $26.54 | $1.87B | $1,063.33 |
| Metric | Value |
|---|---|
| Metric | 40.1x |
| Metric | 30.1x |
| EPS | $26.54 |
| EPS | $29.91 |
| EPS | $60.00 |
| DCF | $2,283.27 |
| Metric | Value |
|---|---|
| 2025 | -12 |
| EPS | $6.61 |
| EPS | $234.0M |
| EPS | $158.4M |
| Pe | $200M |
| Fair Value | $162.0M |
| Fair Value | $3.20B |
| Quarter | Guidance Range | Actual | Within Range (Y/N) | Error % |
|---|
| Quarter | EPS (Diluted) | Revenue | Net Income |
|---|---|---|---|
| Q2 2023 | $26.54 | $1990.9M | $651.9M |
| Q4 2023 | $26.54 | $1990.9M | $651.9M |
| Q1 2024 | $26.54 | $1990.9M | $651.9M |
| Q2 2024 | $26.54 | $1990.9M | $651.9M |
| Q4 2024 | $26.54 | $1990.9M | $651.9M |
| Q1 2025 | $26.54 | $1990.9M | $651.9M |
| Q2 2025 | $26.54 | $1990.9M | $651.9M |
| Q4 2025 | $26.54 | $1990.9M | $651.9M |
We do not have direct alternative-data feeds in the spine for job postings, web traffic, app downloads, or patent filings, so the quantitative read is necessarily limited. In that context, the most useful signal is what the audited and survey data imply about product stickiness: the institutional survey assigns Earnings Predictability = 100, and the evidence claims note that FICO Scores are used by 90% of top lenders (non-EDGAR, qualitative only).
For an investor, that combination suggests the right alternative-data question is not whether FICO is gaining awareness, but whether usage intensity and pricing power are still compounding. If job postings, patenting activity, or web engagement accelerate from here, that would likely corroborate the current operating trend of +19.3% revenue growth; if they flatten while revenue keeps growing, it would imply the model is more contract-driven and less expansionary than the current earnings momentum suggests. Because those datasets are not present here, treat this as a monitoring framework rather than a quantified confirmation.
Institutional sentiment is constructive rather than euphoric. The proprietary survey ranks FICO Safety 3, Timeliness 3, and Technical 3, with Financial Strength B+ and Price Stability 40. That reads as a high-quality company with some balance-sheet and timing caution, not a crowded defensive name with flawless sponsorship.
Retail sentiment is harder to infer from the spine, but the market price of $1,063.33 versus a DCF fair value of $2,283.27 suggests investors are already assigning a substantial premium to the franchise’s earnings durability. Put differently, the stock is not being ignored; it is being valued as a premium asset, and the burden of proof is on continued cash conversion and debt control to justify that premium over time.
| Category | Signal | Reading | Trend | Implication |
|---|---|---|---|---|
| Growth | Revenue growth YoY | +19.3% | IMPROVING | Demand/monetization remains strong |
| Growth | Net income growth YoY | +27.1% | IMPROVING | Operating leverage is intact |
| Profitability | Operating margin | 46.5% | Stable to improving | Core economics remain premium |
| Profitability | Gross margin | 14.1% | Mixed | Low gross profit suggests unusual cost structure… |
| Liquidity | Current ratio | 0.93 | Deteriorating | Short-term cushion is thin |
| Leverage | Long-term debt | $3.20B | RISING | Debt load is expanding |
| Capital structure | Shareholders' equity | -$1.81B | Deteriorating | Book equity remains deeply negative |
| Cash generation | Free cash flow | $769.885M | Strong | Supports valuation and debt service |
| Valuation | DCF fair value vs spot | $2,283.27 vs $1,063.33 | Favorable | Model says material upside if assumptions hold… |
| Market calibration | Reverse DCF implied growth | -3.6% | Pessimistic | Market implies a harsh long-run outlook |
| Criterion | Result | Status |
|---|---|---|
| Positive Net Income | ✓ | PASS |
| Positive Operating Cash Flow | ✗ | FAIL |
| ROA Improving | ✗ | FAIL |
| Cash Flow > Net Income (Accruals) | ✗ | FAIL |
| Declining Long-Term Debt | ✗ | FAIL |
| Improving Current Ratio | ✓ | PASS |
| No Dilution | ✓ | PASS |
| Improving Gross Margin | ✓ | PASS |
| Improving Asset Turnover | ✓ | PASS |
| Component | Value |
|---|---|
| Working Capital / Assets (×1.2) | -0.029 |
| Retained Earnings / Assets (×1.4) | 0.000 |
| EBIT / Assets (×3.3) | 0.126 |
| Equity / Liabilities (×0.6) | -0.494 |
| Revenue / Assets (×1.0) | 0.202 |
| Z-Score | DISTRESS 0.29 |
| Component | Value | Assessment |
|---|---|---|
| M-Score | -1.95 | Unlikely Unlikely Manipulator |
| Threshold | -1.78 | Above = likely manipulation |
FICO’s liquidity profile cannot be fully quantified Spine because there is no average daily volume, bid-ask spread, institutional turnover series, or market-impact model output. The only directly observable live market data are the $1,063.33 stock price and $25.22B market cap as of Mar 24, 2026, which confirm that the name is large-cap but do not by themselves establish trading friction.
From a portfolio-construction perspective, the missing microstructure inputs are important because block-trade feasibility depends less on headline market cap than on actual daily liquidity and spread behavior. If the block profile were provided, the pane should report days to liquidate a $10M position and expected market impact; absent that data, the safest conclusion is that liquidity remains rather than presumed to be deep or shallow.
The Data Spine does not provide moving-average, RSI, MACD, or volume-trend series, so a factual technical readout cannot be completed without external price history. The only current market anchor is the live price of $1,063.33 as of Mar 24, 2026, which is insufficient to infer whether the stock is above or below its 50-day or 200-day averages.
Because the pane is required to report indicators factually rather than as trading signals, the correct treatment here is to mark the specific technical gauges as . If a price series were supplied, the exhibit should include 50/200 DMA positioning, RSI regime, MACD signal state, and nearby support/resistance levels derived from actual highs and lows.
There is no live options chain, term structure, or historical realized volatility feed in the supplied spine, so a precise IV read cannot be verified. What can be said is that FICO’s current valuation and balance-sheet profile are the kind that often support a premium implied-vol regime: the stock is priced at $1,063.33, with 46.5% operating margin, 38.7% FCF margin, and 30.1x EV/EBITDA. That profile typically keeps optionality expensive because the market is paying for execution durability.
From a model perspective, the stock is not being valued as a low-variance name. The deterministic DCF base value is $2,283.27, while the Monte Carlo median is $967.12 and the 95th percentile is $4,714.72, a spread that signals very wide expected dispersion even before any option-implied inputs are layered in. If a live chain were available, the key comparison would be whether 30-day IV sits above the stock’s realized run-rate implied by the recent earnings cadence of +19.3% revenue growth and +29.8% EPS growth; absent that feed, the best conclusion is that volatility risk is structurally elevated rather than suppressed.
No strike-by-strike tape, block prints, open interest ladder, or institutional options positioning data was included in the spine, so specific unusual trades cannot be verified. Because FICO’s share price is already above $1,000 and the market cap is $25.22B, any actual contract flow would likely be concentrated in higher-notional calls or protective puts with meaningful dollar exposure, but that is an inference, not a confirmed print.
The most relevant positioning clue available is indirect: the market is implicitly choosing between a very strong cash-generation story and a far more conservative growth path. The DCF base case of $2,283.27 versus the reverse DCF implied growth rate of -3.6% suggests that if traders are active in the chain, they will likely express views through longer-duration call spreads or downside hedges rather than simple near-dated directionals. However, without option flow, OI concentrations, or expiry/strike data, all such positioning statements remain .
Short interest as a percentage of float and days to cover are not provided in the spine, so squeeze risk cannot be numerically verified. That said, the leverage and liquidity profile argues against assuming a benign short setup: current ratio is 0.93, long-term debt increased to $3.20B by 2025-12-31, and shareholders’ equity deepened to -$1.81B. Those are the types of fundamentals that can attract structural shorts if growth decelerates.
On the other hand, the operating backdrop is still strong enough to make a squeeze expensive if sellers are wrong. FICO generated $769,885,000 of free cash flow with 8.8x interest coverage, which reduces distress probability even if the balance sheet is leveraged. The net read is that any squeeze risk is more likely to be driven by sentiment and positioning than by a true solvency event; absent verified SI, a prudent classification is on the numeric level and medium on conceptual squeeze sensitivity.
| Expiry | IV | IV Change (1wk) | Skew (25Δ Put - 25Δ Call) |
|---|
| Metric | Value |
|---|---|
| Operating margin | $1,063.33 |
| Operating margin | 46.5% |
| Operating margin | 38.7% |
| Operating margin | 30.1x |
| DCF | $2,283.27 |
| Monte Carlo | $967.12 |
| Monte Carlo | $4,714.72 |
| Revenue growth | +19.3% |
| Metric | Value |
|---|---|
| Market cap | $1,000 |
| Market cap | $25.22B |
| DCF | $2,283.27 |
| DCF | -3.6% |
| Fund Type | Direction |
|---|---|
| HF | Long / Options |
| MF | Long |
| Pension | Long / Hedged |
| HF | Short / Pair Trade |
| MF | Long |
1) De-FICO-ization of underwriting workflows. Probability: High. Price impact: -$300 to -$700 if lenders move to cached scores, alternate models, or internal risk stacks and reduce paid score pulls by a meaningful amount. The specific threshold is a sustained 15%+ decline in paid score usage or a visible shift in mortgage, auto, or card workflows away from score-centric decisioning. This risk is getting closer if adoption of internal risk stacks improves and further if lenders find they can preserve approval quality without paying for repeated FICO pulls.
2) Valuation multiple compression. Probability: Medium. Price impact: -$200 to -$450 if the market stops assigning a premium growth multiple and the P/E re-rates from 40.1x toward the mid-20s. Threshold: earnings growth slows while the multiple remains exposed to higher-for-longer rates or investor skepticism. This risk is getting closer because the market already prices the business at 30.1x EV/EBITDA.
3) Balance-sheet sensitivity from leverage and negative equity. Probability: Medium. Price impact: -$150 to -$400 if EBITDA weakens enough that interest coverage falls materially from 8.8x or if refinancing terms worsen. Threshold: current ratio below 0.75 or debt above $3.5B without commensurate cash generation. This is getting closer because long-term debt already stands at $3.20B while shareholders' equity is -$1.81B.
4) Margin mean reversion. Probability: Medium. Price impact: -$120 to -$300 if operating margin falls below 35% and FCF margin drops under 25%. Threshold: rising price competition or higher customer bargaining power. This risk is getting further in the near term because current margins remain very strong, but it could snap back quickly if volume slows.
5) Regulatory or policy substitution. Probability: Low-Medium. Price impact: -$150 to -$350 if policy changes encourage alternate underwriting standards or weaken the default role of credit scores. Threshold: new rules that reduce score dependence in regulated lending. This is currently on the data spine, but it remains an important competitive-risk kill path because customer captivity can unwind abruptly when rules change.
The strongest bear case is not a sudden collapse in reported earnings; it is a gradual erosion of paid score usage that leaves the company looking healthy on the surface while the underlying franchise loses pricing power. In that path, lenders keep using credit data but increasingly rely on cached scores, alternate models, or internal risk systems, causing revenue growth to decelerate from the current +19.3% YoY to the low single digits or below. Because the business currently earns 46.5% operating margin and 38.7% FCF margin, a small change in workflow economics can still produce a large change in what investors are willing to pay.
Under this bear case, the equity does not need to “blow up” for the thesis to fail. A re-rating to a more ordinary software/data-services multiple alongside softer growth could drive the stock toward the DCF bear value of $947.85, and a deeper de-rating could push it closer to the Monte Carlo low-tail range where the 25th percentile is $550.58. The path is: score pull frequency slows, margins peak, EPS growth normalizes, the market questions the durability of the franchise, and the current 40.1x P/E compresses before management can offset it with new products. In short, the bear case is a durability problem, not a profitability problem.
The bull case says FICO is a durable compounder, but the numbers show a business priced like a near-perfect franchise while carrying a leveraged balance sheet. The contradiction is that the company has 46.5% operating margin and 63.1% ROIC, yet also trades at 40.1x P/E, 30.1x EV/EBITDA, and a current price of $1,063.33 that already reflects substantial durability. If the market is right that FICO deserves a premium, then the reverse DCF should not imply -3.6% growth; if the reverse DCF is right, then the valuation is overstating the permanence of score centrality.
There is also a contradiction between strong current margins and the risk of workflow disintermediation. The bull argument leans on repeatable score usage, yet the data spine shows no direct evidence for segment-level pull growth, customer concentration, or pricing per score. That means the strongest bull proof point is still indirect: profits are high today. The strongest bear counter is direct: if customers can keep underwriting quality while reducing paid pulls, the economics can unwind before revenue visibly falls.
De-FICO-ization mitigant: the franchise still shows +19.3% revenue growth and 26.54 EPS, which indicates score usage remains economically relevant today. The company’s moat is not a single product line in isolation; it is embedded decisioning across lending workflows, and that makes abrupt displacement harder than gradual substitution. What would reduce this comfort is evidence that score-pull frequency or pricing per pull is falling faster than revenue growth.
Leverage mitigant: interest coverage is currently 8.8x and operating cash flow is $778.807M, which gives FICO room to service debt even with some cyclical pressure. Margin mitigant: operating margin of 46.5% and FCF margin of 38.7% imply there is still a lot of cushion before a serious earnings impairment. Competition mitigant: the company’s high R&D intensity at 9.5% of revenue suggests it is still investing enough to defend product relevance, though this is only a partial defense if the workflow itself changes.
| Pillar | Invalidating Facts | P(Invalidation) |
|---|---|---|
| franchise-durability-default-status | A major U.S. mortgage GSE, regulator, or top-tier lender formally replaces FICO as the primary required or default underwriting score for a meaningful share of originations.; VantageScore or another alternative score provider achieves sustained, material market-share gains in U.S. mortgage or consumer lending that are accompanied by lender migration away from FICO rather than dual-running.; FICO is forced to make material price concessions or experiences declining scoring unit economics due to competitive displacement, indicating loss of pricing power. | True 30% |
| product-evolution-vs-disruption | FICO Score 10 / 10 T or other newer scores fail to achieve meaningful production adoption among major lenders within 24 months.; Alternative-data-enabled offerings generate little incremental revenue and primarily cannibalize legacy score volumes or require discounting to drive uptake.; Customers continue to use legacy FICO versions while bypassing newer products, showing that innovation is defensive rather than additive. | True 45% |
| regulatory-model-governance-risk | A regulator, court, or major enforcement action imposes material restrictions on the use, explainability, data inputs, or pricing of FICO scores.; Fair-lending or consumer-data rules materially limit use of alternative data or black-box modeling in a way that impairs FICO's product roadmap or economics.; FICO experiences a material compliance failure, model-governance breakdown, or adverse supervisory finding that causes customers to suspend or reduce score usage. | True 28% |
| volume-sensitivity-vs-resilience | During a lending slowdown, FICO's scoring revenue declines materially more than expected and does not demonstrate offsetting resilience from pricing, account mix, or software revenue.; Management guidance or reported results show earnings are highly correlated with mortgage and consumer origination volumes, contradicting the resilience thesis.; Software revenue also weakens meaningfully during the same period due to delayed customer spending, proving both segments are cycle-sensitive at once. | True 40% |
| economics-quality-and-capital-allocation… | Reported margins or free-cash-flow conversion deteriorate materially and persistently without a credible temporary explanation.; FICO's leverage rises to a level that constrains buybacks, raises refinancing risk, or exposes the business to balance-sheet stress.; There is evidence of aggressive accounting, materially poor earnings quality, or data/model issues that require restatement, remediation, or customer compensation. | True 25% |
| valuation-mispricing-vs-expectation-risk… | Consensus or management expectations for growth, margins, and durability are already fully reflected in valuation multiples that leave little upside under reasonable scenarios.; Any modest slowdown in score adoption, pricing, or lending volumes causes a large derating, indicating the stock embeds optimistic permanence assumptions.; Comparable quality software/data businesses trade at meaningfully lower multiples after adjusting for growth, cyclicality, and concentration, undermining the undervaluation case. | True 55% |
| Trigger | Threshold Value | Current Value | Distance to Trigger (%) | Probability | Impact (1-5) |
|---|---|---|---|---|---|
| Revenue growth decelerates below 10% YoY for 2 consecutive quarters… | < 10% | +19.3% | 53.4% | MEDIUM | 4 |
| Operating margin falls below 35% | < 35% | 46.5% | 33.8% | MEDIUM | 4 |
| Free cash flow margin falls below 25% | < 25% | 38.7% | 35.3% | MEDIUM | 4 |
| Current ratio declines below 0.75 | < 0.75 | 0.93 | 19.4% | LOW | 5 |
| Long-term debt rises above $3.5B without offsetting EBITDA growth… | >$3.5B | $3.20B | 8.6% | MEDIUM | 5 |
| Competitive displacement: paid score pulls or score-centric workflows decline 15%+… | <-15% usage | — | — | HIGH | 5 |
| P/E compresses below 25x while earnings growth normalizes… | < 25x | 40.1x | 37.7% | MEDIUM | 4 |
| Metric | Value |
|---|---|
| Revenue growth | +19.3% |
| Operating margin | 46.5% |
| FCF margin | 38.7% |
| DCF | $947.85 |
| Monte Carlo | $550.58 |
| P/E | 40.1x |
| Amount | Refinancing Risk |
|---|---|
| $3.20B long-term debt outstanding | HIGH |
| Metric | Value |
|---|---|
| Operating margin | 46.5% |
| ROIC | 63.1% |
| P/E | 40.1x |
| EV/EBITDA | 30.1x |
| P/E | $1,063.33 |
| Growth | -3.6% |
| Failure Path | Root Cause | Probability (%) | Timeline (months) | Early Warning Signal | Current Status |
|---|---|---|---|---|---|
| Score usage shifts to cached or alternate models… | Competitors and lenders reduce paid FICO pulls; workflow becomes less captive… | 35% | 6-18 | Slowing revenue growth despite stable loan volumes… | Watch |
| Price war or bundled analytics undercuts score economics… | A rival or consortium offers cheaper decisioning tools, forcing pricing concessions… | 20% | 12-24 | Gross margin slips and customer commentary emphasizes price pressure… | Watch |
| Refinancing or leverage shock | Negative equity and $3.20B debt magnify sensitivity to higher rates or lower EBITDA… | 15% | 6-24 | Interest coverage trends below 7x or debt increases further… | Watch |
| Multiple compression after growth normalization… | Investors stop paying for perfection as EPS growth moderates… | 25% | 3-12 | P/E falls below 30x with no offsetting acceleration… | Watch |
| Regulatory substitution risk | Policy or GSE changes reduce the default role of score-centric underwriting… | 10% | 12-36 | RFP language or policy statements emphasize alternate models… | Safe |
| Execution miss on product innovation | R&D fails to preserve relevance as decisioning tech evolves… | 15% | 12-24 | Flat or declining R&D productivity versus revenue growth… | Watch |
| Pillar | Counter-Argument | Severity |
|---|---|---|
| franchise-durability-default-status | [ACTION_REQUIRED] The pillar likely overstates the durability of FICO's 'default' position because default status in cre… | True high |
| product-evolution-vs-disruption | [ACTION_REQUIRED] The pillar may be wrong because it assumes product evolution automatically translates into economic ex… | True high |
| regulatory-model-governance-risk | This pillar is vulnerable because FICO’s economics depend on a regulated, politically sensitive chokepoint: a quasi-stan… | True high |
| valuation-mispricing-vs-expectation-risk… | [ACTION_REQUIRED] The undervaluation case may be backwards: FICO's current valuation can be explained only if investors… | True high |
| valuation-mispricing-vs-expectation-risk… | [ACTION_REQUIRED] The core competitive assumption behind undervaluation may be too generous: FICO's score dominance may… | True high |
| valuation-mispricing-vs-expectation-risk… | [ACTION_REQUIRED] The market may be overcapitalizing historical score price increases that were driven by a specific ind… | True high |
| valuation-mispricing-vs-expectation-risk… | [ACTION_REQUIRED] The software segment may be assigned too high a quality multiple relative to its true competitive posi… | True medium |
| valuation-mispricing-vs-expectation-risk… | [ACTION_REQUIRED] FICO's end-market exposure creates expectation risk that may be underappreciated in valuation. Even if… | True high |
| valuation-mispricing-vs-expectation-risk… | [ACTION_REQUIRED] Capital allocation optics may be flattering valuation support more than true operating undervaluation. | True medium |
| valuation-mispricing-vs-expectation-risk… | [NOTED] The thesis's own kill file already points toward the most likely failure mode: this is less a debate about franc… | True high |
| Component | Amount | % of Total |
|---|---|---|
| Long-Term Debt | $3.2B | 100% |
| Cash & Equivalents | ($162M) | — |
| Net Debt | $3.0B | — |
FICO scores well on business quality but only partially clears Buffett’s harder qualitative hurdles. The company’s 2025 economics are unusually strong, with 46.5% operating margin, 38.7% FCF margin, and 63.1% ROIC, which are consistent with a business that can compound capital without much reinvestment. That said, the supplied evidence does not directly prove moat durability; the spine explicitly notes that switching costs, regulatory acceptance, and competitor displacement are not well evidenced.
On a 1–5 scale, I would rate: understandable business 3/5 because the credit decisioning role is clear but revenue composition is not fully decomposed; favorable long-term prospects 4/5 because per-share economics are still growing rapidly; able/trustworthy management 3/5 because no guidance, transcript, or governance evidence was supplied in the spine; and sensible price 2/5 because the stock trades at 40.1x earnings and 14.2x revenue. In Buffett terms, this is a quality business priced like one, but with too little moat evidence to call it obviously cheap.
EDGAR context: the 2025 audited financial pattern suggests a durable cash engine, but the 10-K/10-Q evidence provided here is financial, not strategic, so the qualitative moat case remains inferential rather than proven.
FICO fits best as a high-quality compounder rather than a deep-value or balance-sheet repair idea. I would size it as a small-to-medium core position only for a portfolio that can tolerate rich multiples and leverage, because the upside case is driven by continued execution, not by obvious re-rating from cheapness. The current setup is attractive if you believe 2026–2027 per-share earnings of $41.15 and $52.50 remain achievable; it is much less attractive if growth normalizes while debt remains elevated at $3.20B.
Entry criteria should focus on price discipline and fundamental continuity: I would want either a material pullback from $1,063.33 or evidence that growth is accelerating enough to justify the premium. Exit criteria: a sustained revenue growth slowdown from 19.3% YoY, any deterioration in cash conversion below the current 38.7% FCF margin, or further leverage expansion without matching per-share acceleration. This clears the circle-of-competence test only if the investor is comfortable underwriting decisioning/franchise economics and can live with limited transparency on moat mechanics. In other words, the business is understandable enough, but the valuation requires conviction that the economic toll bridge stays intact.
My conviction score is 6.3/10, reflecting a strong business wrapped in a demanding price and a less-than-comfortable balance sheet. The pillars below are weighted toward cash generation and valuation because those are the two most decision-relevant factors in this name.
Weighted total: 6.3/10. The score would move materially higher if the company supplied stronger moat disclosure and a cleaner capital structure; it would move lower if growth slips below the current 19.3% pace while leverage keeps rising.
| Graham criterion | Threshold | Actual value | Pass/Fail |
|---|---|---|---|
| Adequate size of enterprise | Meaningful market presence | Market cap $25.22B | PASS |
| Strong financial condition | Current ratio >= 2.0 and modest leverage… | Current ratio 0.93; equity -$1.81B | FAIL |
| Earnings stability | Positive and stable over 10 years | 10-year series not provided… | UNVERIFIED |
| Dividend record | At least 20 years of uninterrupted dividends… | $0.00 dividend/share (2025 estimate); no dividend record supplied… | FAIL |
| Earnings growth | Positive 7-year growth threshold | EPS growth YoY +29.8%; revenue growth YoY +19.3% | PASS |
| Moderate P/E | P/E <= 15.0 | P/E 40.1 | FAIL |
| Moderate P/B | P/B <= 1.5 | Book value/share negative; P/B not meaningful… | FAIL |
| Metric | Value |
|---|---|
| Operating margin | 46.5% |
| FCF margin | 38.7% |
| ROIC | 63.1% |
| Understandable business | 3/5 |
| Favorable long-term prospects | 4/5 |
| Sensible price | 2/5 |
| Earnings | 40.1x |
| Revenue | 14.2x |
| Bias | Risk level | Mitigation step |
|---|---|---|
| HIGH Anchoring | Use DCF base $2,283.27, reverse DCF, and Monte Carlo median $967.12 as separate anchors instead of a single price target… | Watch Re-run valuation under lower growth and higher WACC cases… |
| HIGH Confirmation | Force a bear case around leverage, negative equity, and moat uncertainty… | Flagged |
| MED Recency | Test 2025 acceleration against prior periods and longer-run trend; do not extrapolate one strong year blindly… | Watch |
| MED Base-rate neglect | Compare 40.1x P/E and 30.1x EV/EBITDA with other high-quality information services franchises… | Watch |
| HIGH Overconfidence | Use scenario range of $947.85 to $5,372.52 and Monte Carlo 5th/95th of $211.94/$4,714.72… | Watch |
| MED Narrative fallacy | Separate cash-generation facts from unsupported moat claims… | Clear |
| MED Loss aversion | Pre-commit to exits if leverage rises beyond current $3.20B with no EPS compounding… | Watch |
| Metric | Value |
|---|---|
| Metric | 3/10 |
| ROIC | 63.1% |
| Operating margin | 46.5% |
| FCF margin | 38.7% |
| Revenue growth | 19.3% |
| EPS growth | 29.8% |
| EPS growth | $52.50 |
| Equity | $1.81B |
FICO’s management profile reads as high-conviction execution with a meaningful financial-risk overlay. The company posted +19.3% revenue growth, +27.1% net income growth, 46.5% operating margin, and 38.7% free-cash-flow margin in FY2025, which is exactly the type of operating momentum that supports a premium multiple. That performance suggests management is not dissipating the moat; it is reinforcing it through pricing power, scale economics, and disciplined expense control.
At the same time, the capital structure is aggressive enough to matter. Long-term debt increased from $2.41B at 2024-12-31 to $3.20B at 2025-12-31, current ratio was only 0.93, and shareholders’ equity was -$1.81B. That means the operating moat is real, but it is being amplified by leverage rather than by a conservative balance sheet. In portfolio terms, this is a management team building earnings density and cash conversion, but doing so on a narrower margin of safety than peers such as Equifax, Verisk Analytics, and Broadridge Financial referenced in the institutional survey.
Because no proxy statement, Form 4 stream, or executive biographies were provided in the spine, I cannot verify CEO tenure, insider ownership, or specific succession planning. The evidence available nonetheless supports a positive view on day-to-day execution and a more cautious view on capital structure discipline. If the company sustains FY2025 economics without further debt escalation, management deserves a premium quality score; if growth slows and leverage remains elevated, the same operating strength could be offset by constrained flexibility.
No board composition, independence table, or shareholder-rights disclosure was included in the spine, so governance quality cannot be verified. That is a material gap because FICO’s financial structure is not trivial: long-term debt reached $3.20B, total liabilities were $3.66B, and shareholders’ equity was -$1.81B at 2025-12-31. In a business that already trades at 40.1x P/E and 30.1x EV/EBITDA, the board’s independence and capital-allocation discipline matter more than usual.
From a governance lens, the key question is whether oversight is sufficiently rigorous to prevent leverage from being used as a permanent crutch for equity returns. The company’s 0.93 current ratio and negative book equity mean there is less room for operational slippage than the headline cash generation might imply. Until the company provides clearer proxy disclosure, I would treat governance as a watch item rather than a confirmed strength.
Compensation alignment with shareholder interests cannot be assessed from the spine because no DEF 14A, pay mix, performance-vesting schedule, or CEO realizable-pay history was provided. That said, the economic backdrop implies a high bar for pay-for-performance alignment: the company delivered $769,885,000 of free cash flow in FY2025, while the market values the business at $25.22B and the stock at $1,063.33 as of Mar 24, 2026.
In a name with negative shareholders’ equity, $3.20B of long-term debt, and a premium multiple, the ideal compensation plan would reward sustained EPS growth, cash conversion, and balance-sheet discipline rather than headline revenue alone. Without the proxy, I cannot verify whether management is paid on those dimensions or whether incentives encourage leverage tolerance. This is a genuine diligence gap, not a minor omission.
The spine does not include insider ownership percentages, Form 4 transactions, or 10b5-1 activity, so recent insider buying/selling cannot be verified. That makes it impossible to determine whether management is materially aligned through direct ownership or whether insiders have been net sellers/buyers around the current $1,063.33 share price.
For a company with a $25.22B market cap, 23.8M shares outstanding, and a premium valuation profile, insider disclosure would be especially useful because even small insider ownership percentages can influence perceived alignment. Until that data is available, the best available proxy for alignment is operational consistency: stable shares outstanding, strong cash conversion, and sustained per-share growth in the institutional survey.
| Metric | Value |
|---|---|
| Revenue growth | +19.3% |
| Net income | +27.1% |
| Operating margin | 46.5% |
| Free-cash-flow margin | 38.7% |
| Fair Value | $2.41B |
| Fair Value | $3.20B |
| Pe | $1.81B |
| Title | Background | Key Achievement |
|---|---|---|
| CEO / Executive Chairman | No executive roster provided in the spine; EDGAR biography unavailable here. | FY2025 revenue growth of +19.3% and operating margin of 46.5% indicate effective operating leadership. |
| CFO | No CFO biography or appointment date provided in the spine. | Managed through a year with long-term debt rising to $3.20B while free cash flow remained $769,885,000. |
| Chief Technology / Product Officer | No named technology/product executive provided in the spine. | R&D remained controlled at 9.5% of revenue, supporting continued product investment. |
| Chief Commercial / Sales Officer | No commercial leadership disclosure provided in the spine. | Revenue/share rose from $70.41 in 2024 to $83.78 in 2025 (institutional survey). |
| Head of Investor Relations / Corp. Development | No IR or corp dev leadership disclosure provided in the spine. | Market continues to value FICO at P/E 40.1 and EV/EBITDA 30.1, indicating the narrative is being maintained. |
| Metric | Value |
|---|---|
| Fair Value | $3.20B |
| Fair Value | $3.66B |
| Fair Value | $1.81B |
| P/E | 40.1x |
| EV/EBITDA | 30.1x |
| Dimension | Score (1-5) | Evidence Summary |
|---|---|---|
| Capital Allocation | 3 | FY2025 free cash flow was $769,885,000 and share count was stable at 23.8M, but long-term debt rose from $2.41B (2024-12-31) to $3.20B (2025-12-31). No buyback/dividend/M&A cash deployment data were provided. |
| Communication | 3 | No guidance or earnings-call transcript was provided; therefore guidance accuracy cannot be judged. The business still shows strong reported outcomes with revenue growth of +19.3% and EPS growth of +29.8%. |
| Insider Alignment | 2 | Insider ownership and Form 4 activity were not provided in the spine, so alignment cannot be confirmed. Lack of ownership disclosure is a visibility gap, especially with a $25.22B market cap and premium valuation. |
| Track Record | 4 | FY2025 delivered +19.3% revenue growth, +27.1% net income growth, 46.5% operating margin, and 38.7% FCF margin. The business also showed stable shares outstanding at 23.8M, supporting per-share compounding. |
| Strategic Vision | 4 | R&D was 9.5% of revenue and SG&A 25.8% of revenue in FY2025, indicating ongoing product investment with operating discipline. The model appears focused on reinforcing pricing power and scale rather than sprawling into low-return growth. |
| Operational Execution | 5 | Operating margin was 46.5%, net margin 32.7%, ROIC 63.1%, and operating cash flow $778,807,000 in FY2025. Execution clearly translated into cash and profitability despite leverage. |
| Overall weighted score | 3.9 / 5 | Strong operating execution and good strategic discipline are partially offset by leverage, limited disclosure, and unverified insider/governance data. |
FICO appears to be in a maturity-to-re-rating phase rather than early growth or turnaround. The company is no longer proving its model; instead, it is monetizing a mature moat with a newly visible earnings acceleration, as shown by +19.3% revenue growth in 2025, $924.9M of operating income, and $769.885M of free cash flow.
At the same time, the business cycle is being complicated by balance-sheet stress. Long-term debt rose from $2.41B at 2024-12-31 to $3.20B at 2025-12-31, while shareholders’ equity deteriorated to -$1.81B. That means the equity story is being driven more by cash flow durability and pricing power than by balance-sheet conservatism.
In cycle terms, this is the kind of company that can continue to command a premium if operating momentum holds, but whose stock is vulnerable to multiple compression if growth normalizes. The live price of $1,063.33 sits well below the deterministic DCF value of $2,283.27, yet above the Monte Carlo median of $967.12, which is consistent with a market that believes in the franchise but not in a straight-line continuation of peak conditions.
The repeated pattern in FICO’s history is straightforward: when the company can keep the franchise in force, it translates relatively modest reinvestment into outsized cash generation. The 2025 profile is the clearest expression of that pattern: $778.807M of operating cash flow against only $8.9M of capex, with ROIC at 63.1% and ROA at 35.2%. That is not a one-off accounting trick; it is the financial fingerprint of a business with embedded economics and low incremental capital needs.
Another repeat behavior is financial engineering layered on top of operating excellence. The balance sheet has consistently become more levered in 2025, with liabilities rising to $3.66B and current ratio at 0.93. Historically, that kind of structure can amplify equity returns when the operating engine is healthy, but it also leaves less room for error if growth or cash conversion stalls. The pattern suggests management has been willing to prioritize shareholder economics and capital efficiency over balance-sheet simplicity.
For investors, the practical read-through is that FICO behaves like a business that is rewarded for execution and punished for any hint of deceleration. That pattern is familiar in premium information-services names: the operating model can support very high valuation for a long time, but the stock often resets sharply when the market decides the growth re-rating has already been harvested.
| Verisk Analytics (2000s–2010s) | Built a high-switching-cost information-services franchise… | Like FICO, the core value proposition is recurring decision infrastructure with limited reinvestment needs and strong pricing power. | The market rewarded durable margins and recurring growth with a premium multiple for years. | FICO may sustain premium valuation if its 2025 revenue growth of +19.3% and FCF margin of 38.7% prove durable. |
| Broadridge Financial (post-spinout period) | Evolved into a compounding, asset-light financial infrastructure provider… | Operating leverage and low CapEx intensity resembled FICO’s 2025 profile, where CapEx was only $8.9M. | The stock compounded as investors learned to underwrite cash flow more than accounting book value. | FICO’s negative equity should matter less than cash generation if FCF stays near $769.885M, but the market will demand evidence. |
| Equifax (post-data moat re-rating) | Business quality re-rated after investors focused on data assets and pricing power… | FICO’s pricing power and decisioning role can be viewed similarly: the moat is in embedded workflow, not physical assets. | Re-rating came with operational execution, but leverage and execution stumbles periodically compressed the multiple. | FICO’s EV/EBITDA of 30.1 suggests the market already pays for quality; any slowdown could hit the multiple hard. |
| Adobe (subscription-era transition) | Shift from transactional economics to higher predictability and cash conversion… | The analogy is not product similarity, but the move from underappreciated economics to a premium, cash-rich franchise. | The stock eventually reflected the higher-quality earnings stream, though valuation became sensitive to growth deceleration. | FICO could continue to outperform if investors keep crediting its 46.5% operating margin and 63.1% ROIC as durable. |
| Early-stage debt-financed compounding franchises… | High returns, but balance-sheet risk grows as leverage rises… | FICO’s negative shareholders’ equity of -$1.81B and long-term debt of $3.20B make this the right cautionary analogy. | When growth stayed strong, leverage was tolerated; when growth slowed, downside came from financing structure, not just operations. | The stock can remain strong in an upcycle, but the balance sheet creates a sharper drawdown path if cash conversion weakens. |
| Metric | Value |
|---|---|
| Revenue growth | +19.3% |
| Revenue growth | $924.9M |
| Revenue growth | $769.885M |
| Fair Value | $2.41B |
| Fair Value | $3.20B |
| Fair Value | $1.81B |
| Fair Value | $1,063.33 |
| DCF | $2,283.27 |
Want this analysis on any ticker?
Request a Report →